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Introduction and Literature 
 
1 Introduction and Literature 
The term “colic” is a broad term for a variety of conditions that cause clinical signs of 
abdominal pain in horses and usually involving the gastrointestinal tract (GRATZL 1942). 
Consequently, it is not a true disease, but a manifestation of underlying disorders of widely 
different etiologies and severities which are generally caused by intestinal spasm or disorders 
of intestinal motility (GRATZL 1952; JAKSCH 1982). Intestinal obstruction is the most 
common form of colic in horses admitted to animal hospitals (WHITE and LESSARD 1986). 
It can vary from a simple intestinal obstruction to a life-threatening strangulation obstruction 
(HUSKAMP et al. 2005).  
Simple intestinal obstruction is caused by occlusion of the intestinal lumen by impacted 
ingesta or by external compression without initial vascular compromise. It is made up of 
35.5% to 37.5% of horses with colic referred to animal hospitals (WHITE 1987; GROSCHE 
2000). Impaction of the large colon with dehydrated ingesta makes up the largest group of 
simple obstruction in horses which is normally diagnosed in the left ventral colon and/or in 
the pelvic flexure (WHITE and LESSARD 1986; WHITE 1990; SULLINS 1990; GROSCHE 
2000). The specific causes and pathogenesis of impactions are not fully understood. Parasite 
infection or migration, motility disorders, dental abnormalities, dietary or management 
factors, and reduced water intake are often implicated (GRATZL 1934; SULLINS 1990). 
Whatever the cause, the horses with impactions should not be fed until the impaction is no 
longer palpable per rectum and fecal output has returned to normal frequency (JAKSCH 
1982, WHITE and DABAREINER 1997). The average time to clear the impaction is 48 
hours, but it can take as longer as 6 to 7 days (DABAREINER and WHITE 1995 
SCHUSSER and SPALLEK 2009). During this period, the horse is under stress of feed 
restriction and pain. Stress-induced cortisol secretion promotes fat mobilization from adipose 
tissue by lipolytic enzymes, which degrade adipose triglycerides (TG) and release non-
esterified free fatty acids (NEFA) into the circulation (BAGDADE and BIERMAN 1970; 
JOHNSON et al. 2004). The released NEFA were extracted by liver, reesterified to 
triglycerides in hepatocytes and released back into blood as very low density lipoprotein 
(VLDL) (BAUER and RANSONE 1983). The elevation of NEFA level in circulation can 
compete with unconjugated bilirubin at ligand-binding proteins of the hepatocyte. This 
affects the affinity of conjugation of bilirubin at the liver leading to increase of unconjugated 
bilirubin and total bilirubin in circulation (NAYLOR et al. 1980b). Simultaneously, the 
elevation of free fatty acid concentration in plasma induces oxidative stress by generation of 
reactive oxygen species (ROS). ROS stimulate proinflammatory cytokines (TRIPATHY et al. 
2003) which play a direct role in development of insulin resistance (KROGH-MADSEN et al. 
2006 and VICK et al. 2007). This could indirectly increase susceptibility of horses to 
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inflammatory processes such as laminitis, phlebitis or metabolic diseases such as 
hyperlipidemia or hyperlipemia during the period of hospitalization.  
Another type of intestinal obstruction is strangulation obstruction which is external vascular 
constriction with simultaneous blockage of intestinal lumen. It is made up between 16.3% 
and 18.4% of colic cases admitted to the hospital (GROSCHE 2000; WHITE 1987). Small 
intestinal strangulation comprises all positional problems either from a twist in the mesentery 
as in the volvulus or from a constriction of blood supply in internal hernias within the 
abdominal cavity. The causes of many displacements are unknown. Abnormal motility, 
acquired defect in mesentery, enlargement of the epiploic foramen or growth of a lipoma 
from mesentery with increasing age is incriminated (KOPF 1985; BLIKSLAGER 2003). 
Colon volvolus is one of intestinal strangulation in which the colon can be twisted 180 to 720 
degrees. The cecum normally becomes strangulated in combination with the large colon. This 
appears to be an age related risk with the mean age of horses being at 7 to 8 years. Brood 
mares are often affected with colon displacement with strangulation near or after parturition. 
Gas distension of the ventral colon with floating of the ventral colon dorsal and medial has 
been a proposed mechanism (HUSKAMP 1984; WHITE 1990). 
Differentiation between strangulation and non-strangulation obstruction is necessary because 
the prognosis varies greatly with each and the choice of treatment used depends on the nature 
of the lesion. Most cases of impactions have a positive response to medical treatment while 
all cases of intestinal strangulation always require surgical correction (KOPF 1984; 
GROSCHE 2000; MAIR et al. 2005). Intestinal ischemia resulting from occlusion of blood 
supply in strangulation obstruction is responsible of the high mortality. Therefore, the 
outcome of these cases is very important especially for the owners due to the high costs of 
surgery and intensive care. Several biochemical parameters were used as prognostic 
indicators of intestinal ischemia but they lack specificity and sensitivity (MOORE et al. 1976; 
JOHNSTONE 1986; REEVES et al. 1989; GARCIA-LOPEZ et al. 2001; SAULEZ et al. 
2004; DELESALLE et al. 2005; HINCHCLIFF et al. 2005).  
The liver seems to be the first organ after intestine that affected by intestinal ischemia as the 
hepatic vasculature is in series with intestinal circulation (HORIE and ISHII 2001). The 
hepatic hypoperfusion elicited by gut ischemia may directly cause liver injury (HORIE et al. 
1996; HORIE et al. 1997). Serum alcohol dehydrogenase (ADH) is a cytosolic hepatic 
enzyme, abundant in centrilobular region of the liver acinus and considered a more sensitive 
biochemical marker of hepatic injury due to vascular disturbance in the liver (SUND et al. 
1963, KATO et al. 1984; KATO et al. 1990). ADH has the smallest molecular weight among 
liver enzymes. Therefore, it can be detected in blood much earlier (PARKS and GRANGER 
1988). Recently, it was proven that ADH activity may be a marker of intestinal ischemia 
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(GUMASTE et al. 2005). Therefore, we assumed that serum ADH activity could increase in 
horses with intestinal strangulation and its level in serum could have a diagnostic and a 
prognostic values in horses with acute intestinal obstruction. 
Finally, the proper management of horses with colic requires controlling of pain without 
masking the signs of strangulating lesion which would indicate the need of surgical 
intervention. N- Butylscopolammonium bromide (Buscopan®) is a spasmolytic drug widely 
used in treatment of colic in horses (DAVIES and GERING 1983). It is an anticholinergic 
drug which acts by blocking the muscarinic receptors and relaxing the intestinal muscles 
(BERTONE 2002). The drug is commercially available in combination with Metamizol-
sodium (non-steroidal anti-inflammatory) as (Buscopan® compositum) for relieving the 
abdominal pain resulting from intestinal spasm in horses. Therefore it’s suitable for treatment 
of spasmodic colic and gas colic as well as spasms occurring oral to and over the intraluminal 
obstruction, such as in mild impaction (BIDWELL 2009). The therapeutic dosage regime of 
N-Butylscopolammonium bromide is based on a single dose and if the drug is given too 
frequently or in an overdosage, it would produce effects analogous to atropine such as 
paralytic ileus (BOATWRIGHT et al. 1996). The equine intestinal tract has regional different 
motility patterns, as the small intestinal motility composed of propulsive and segmental 
contractions and large colon especially left ventral colon motility includes non-rhythmic 
hausteral segmentation and rhythmic propulsive and retropulsive contractions while cecal 
motility is largely composed of segmental contractions (HERDT 2007). Therefore, the effect 
of a single therapeutic dosage of Buscopan® compositum on the segmental motility of 
intestine in healthy horses could differ from region to another which indirectly provides some 
insight into pain relieving effect of Buscopan® compositum on different regions of intestine. 
This work was divided into 3 different studies considering the horses with colic.  
1- Investigation of the fat mobilization in horse with left ventral colon impaction during 
the time of treatment by measuring triglycerides, free fatty acids and total bilirubin at 
admission and immediately after resolving the impaction and refeeding the horses. 
 
2- Evaluation of ADH activity in serum of horses with acute intestinal obstruction and 
whether its level has a diagnostic value in differentiating strangulation obstruction from non-
strangulation obstruction or a prognostic value in horses with intestinal strangulation. 
 
3- Investigation of the effect of Buscopan® compositum at its therapeutic dosage on the 
contractive motility of the duodenum, cecum and left ventral colon in healthy conscious 
horses. This could indirectly determine the regional different effect of Buscopan® 
compositum in relieving the abdominal pain in horses with colic. 
3
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2 Results 
2.1 Publication 1: Triglyceride, free fatty acids and total bilirubin in horses 
with left ventral large colon impaction 
 
Published in: Pferdeheilkunde 2009; 2:137-140 
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Introduction
Horses with colic usually have an alteration in normal meta-
bolic rate influenced by pain, anorexia or feed restriction
during transportation and treatment. These factors are poten-
tial sources of stress in horses, which result in an increase of
energy demand and consequently to a fat mobilization from
adipose tissue (Edner et al. 2007). During this period of colic,
the hormone-sensitive lipase induced by catecholamine con-
verts the fat tissue into free fatty acids (FFAs), or nonesterified
fatty acids and glycerol. The FFAs are bound to plasma albu-
min before transportation to the liver. FFAs will be recombi-
ned with glycerol to make triglycerides in hepatic cell and
secreted into bloodstream as very low density lipoprotein
(Jaworski et al 2007).  
Three conditions of an increase in plasma lipids are descri-
bed in equids: hyperlipemia, hyperlipidemia and hypertrigly-
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Triglycerides, free fatty acids and total bilirubin 
in horses with left ventral colon impaction
Naglaa Gomaa, Gábor Koeller and Gerald F. Schusser
Medizinische Tierklinik, Veterinärmedizinische Fakultät, Universität Leipzig, Germany
Summary
Colic horses are under stress of pain, anorexia or feed restriction during treatment leading to fat mobilization. The objective of this study is
the investigation of fat mobilization in twelve horses with left ventral colon impaction referred to the large animal hospital, University of Leip-
zig. Serum triglycerides (TG), free fatty acids (FFAs) and total bilirubin (TB) were measured at admission and after impaction resolution. Six
healthy horses were used as control in two different protocols. In protocol A the horses were fed twice a day and stabled on straw-bedded
boxes without feed over a period of 12 hours (overnight). In protocol B the same horses were transferred into unbedded boxes without feed
over a period of 12 hours (overnight). Blood was collected in both protocols at 7.00 a.m. before feeding. In horses with impaction serum
FFAs (830.3 µmol/l, median) and TB (75.9 µmol/l) at admission were significantly elevated in comparison with the values of protocol A 
(129.5 µmol/l; 22.5 µmol/l) while serum FFAs did not differ significantly with values in protocol B (395.5 µmol/l). Serum TG 
(0.46 mmol/l) of colic horses at admission and of horses in protocol A (0.46 mmol/l) and B (0.31 mmol/l) did not differ significantly. These
values were still in normal limits. Serum TG and TB of colic horses at impaction resolution (1.59 mmol/l, P≤ 0.05; 92.9 µmol/l) were higher
than at admission (0.46 mmol/l, 75.9 µmol/l). At impaction resolution FFAs were lower (553.45 µmol/l) than at admission 
(830.3 µmol/l). Serum triglycerides, FFAs and TB returned to normal in 58.3%, 50% and 25% of colic horses respectively after impaction reso-
lution. We concluded that the horses with left ventral colon impaction undergo fat mobilization during the period of impaction. This was cha-
racterized by mild hypertriglyceridemia and hyperbilirubinemia which are reversible and return to normal after impaction resolution and fee-
ding of the animal. It is recommended that horses with prolonged impaction more than two days and/or increased serum TG >2.26 mmol/l
should receive partial parenteral nutrition to reduce fat mobilisation and to decrease release of inflammatory cytokines from adipose tissue. 
Keywords: free fatty acids, triglycerides, bilirubin, left ventral colon impaction, horse
Triglyceride, freie Fettsäuren und Gesamtbilirubin bei Pferden mit Verstopfung der linken ventralen Längslage des großen
Kolons
Die Kolik bei Pferden kann aufgrund der Schmerzen, Anorexie oder des Futterentzuges während der Behandlung zur Fettmobilisation führen.
Die Fettmobilisation bei zwölf Pferden mit Verstopfung der linken ventralen Längslage des großen Kolons wurde mit Hilfe der Triglyzeride (TG),
freien Fettsäuren (FFS) und des Gesamtbilirubins (GB) im Blut charakterisiert. TG, FFS und GB wurden zum Zeitpunkt der Aufnahme und
nach der Lösung der Verstopfung analysiert und verglichen. Zum Vergleich wurden sechs gesunde, erwachsene Pferde herangezogen, die
zweimal täglich gefüttert wurden und während der Nacht (12 Stunden) ohne Futter waren, jedoch in Boxen mit Stroheinstreu gehalten wur-
den (Protokoll A). Im Protokoll B wurden die selben Pferde in einem zweiten Durchgang in Boxen ohne Einstreu über Nacht (12 Stunden)
gehalten und ebenfalls nicht gefüttert. Die Blutproben wurden bei beiden Gruppen vor der Fütterung am nächsten Tag um 
7 Uhr früh genommen. Die FFS (830,3 µmol/l, median) und das GB (75,9 µmol/l) der Pferde mit Verstopfung bei Aufnahme waren signifi-
kant höher als die Werte des Protokolles A (129,5 µmol/l; 22,5 µmol/l), wobei die Werte des Protokolles B  (395,5 µmol/l) nicht signifikant
unterschiedlich waren. Die Werte der TG der Kolikpferde (0,46 mmol/l), der des Protokolles A (0,46 mmol/l) und des Protokolles B (0,31
mmol/l) differierten nicht signifikant und waren im Normalbereich. Zum Zeitpunkt der Verstopfungslösung waren TG (1,59 mmol/l, P≤ 0,05)
and GB (92,9 µmol/l) höher als bei Klinikaufnahme (0,46 mmol/l, 75,9 µmol/l). Dagegen die FFS waren niedriger 
(553,45 µmol/l) zum Zeitpunkt der Verstopfungslösung im Vergleich zur Aufnahme (830,3 µmol/l). Die Werte der TG, FFS und des GB kehr-
ten bei 58,3 %, 50 % und 25 % der Kolikpferde nach Verstopfungslösung in den Normalbereich zurück. Zusammenfassend wird festgehal-
ten, dass Pferde mit Verstopfung der Fettmobilisation unterliegen. Die Hypertriglyzeridämie und Hyperbilirubinämie sind nach Fütterung rever-
sibel. Besteht jedoch die Verstopfung mehr als zwei Tage und/oder die TG sind höher als 2,26 mmol/l wird eine partiell parenterale Ernäh-
rung empfohlen, damit die Fettmobilisation und die Freisetzung von Entzündungsmediatoren aus dem Fettgewebe reduziert werden.
Schlüsselwörter: Freie Fettsäuren, Triglyceride, Bilirubin, Verstopfung, Pferd
N. Gomaa et al.
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ceridemia. The severe condition is called hyperlipemia that
appears commonly in ponies, donkeys, mules and miniature
horses due to negative energy balance. The plasma has a
white-to-yellow opacity caused by a high concentration of tri-
glycerides above 5.7 mmol/l with fatty infiltration of liver and
multiple organ systems. Hyperlipidemia is the mild form affec-
ting the horses and characterized by triglycerides concentra-
tion below 5.7 mmol/l and clear plasma without evidence of
hepatic dysfunction (Naylor et al 1980, Watson et al 1992,
Mogg and Palmer 1995). Hypertriglyceridemia is defined as
an elevation of serum triglyceride concentration above the
normal range (<1.13 mmol/l) and is not always associated
with evidence of clinical signs (Naylor 1982).
There are many studies on equine hyperlipidemia as a
secondary complication associated by withholding of feed
and gastrointestinal diseases in ponies and miniature horses
(Schotman and Wagenaar 1969, Bartley 1970, Weik and
Altmann 1971, Morris et al. 1972, Freestone et al. 1991,
Mogg and Palmer 1995). However, Milne et al 1990 descri-
bed that the fat mobilization in horses with colic does not
reach the level of hyperlipemia. Dunkel and McKenzie 2003
reported a condition of sever hypertriglyceridemia in adult
horses with serum triglycerides concentration >5.7 mmol/l
without plasma opacity or evidence of clinical effect. The
most common primary diseases in these horses were enter-
itis and colitis.
The increase of FFAs concentration in plasma induces indi-
rectly mitochondrial reactive oxygen species (ROS) (Ceriello
and Motz 2004). ROS has a pro-inflammatory effect and
increases pro-inflammatory cytokines (Tripathy et al. 2003).
Tumor necrosis factor (TNF-α), one of pro-inflammatory cyto-
kines that suppresses lipoprotein lipase synthesis in adipocy-
tes and impairs the insulin action and consequently the con-
centration of triglycerides in plasma are increased (Grunfeld
and Feingold 1991, Nakamura 1998). Therefore, there is an
interrelationship among fat mobilization, insulin resistance
and inflammatory process in horses (Vick et al. 2007). 
The present study aims to investigate the fat mobilisation cha-
racterized by measuring of serum FFAs, triglycerides and total
bilirubin in horses with left ventral colon impaction which are
under feed restriction during the period of treatment.
Materials and Methods 
Medical records of 39 horses with left ventral colon impaction
were reviewed. These horses were presented to the hospital of
large animal medicine, Faculty of Veterinary Medicine, Uni-
versity of Leipzig between January 2005 and February 2008.
Signalment, clinical signs, physical examination findings,
duration of clinical signs, the treatment’s duration and results
of laboratory analysis (cell blood count, total protein, serum
triglycerides, FFAs, total bilirubin) were obtained from the
medical records at admission and after resolving of impac-
tion. The diagnosis of impaction in the left ventral large colon
and resolution based on rectal palpation. 
Six apparently healthy adult Warmblood horses are used as
control horses with two different protocols: Protocol A inclu-
ded horses which were fed two times a day (1,5 kg hay/100
Triglycerides, free fatty acids and total bilirubin in horses with left ventral colon impaction
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kg b.w. and 1 kg carrots per day) and stabled on straw-bed-
ded boxes. Next day after feeding, all horses were transferred
into unbedded boxes without feeding but with free access to
water for 12 hours during the night (protocol B). In protocol
A, venous blood samples were collected from jugular vein at
7:00 a.m. before feeding. The next samples were taken after
2, 3, 4, and 5 hours of feeding. In protocol B, venous blood
samples were collected at 7:00 a.m. in the next day. After
standing 30 minutes at room temperature, the blood samples
were centrifuged at 450g for 10 min. The serum samples
were collected and kept at -20°C until they were analyzed.
Automatic analyzer (Hitachi 912, Boehringer Mannheim) was
used for measuring triglycerides, FFAs and total biliubin in
serum samples.
Statistical analysis
The data were analyzed using the statistical computer pro-
gramme SPSS15 (SPSS-software GmbH, Munich). Descriptive
statistical analysis (mean ± sd, median, minimum and maxi-
mum) of clinical findings, concentrations of serum triglyceri-
des, FFAs and total bilirubin were calculated in horses with
impaction at admission and after resolve of impaction as well
as in control horses. Paired samples T test was used to com-
pare within control horses in protocol A and B.  Wilcoxon Sig-
ned Rank test was used to compare between horses with
impaction at admission and after treatment. Mann-Whitney
U- Test was used for comparison between protocol A before
feeding and horses with impaction at admission and after
resolving of impaction. Nonparametric correlation between
triglycerides, FFAs and total bilirubin at admission and after
resolving of impaction was measured using Spearman’s test.
Significance was established at a level of P≤ 0.05.
Results
Only 12/39 horses with clinical pathological findings of tri-
glycerides, FFAs and total bilirubin were found at admission
and after resolution of the impaction. Eight mares, three gel-
dings and one stallion of various breeds (nine Warmbloods,
two Thoroughbreds, one German riding pony) were 3-22
years old (median 7 years). At admission heart, respiratory
rates and rectal temperatures in these horses were
46.5±6.9/min, 18.5±4.9/min and 37.7±0.6°C respective-
ly. 10/12 horses had normal mucous membranes and only
two horses had congested and mild icteric mucous membra-
nes. All horses had reduced intestinal sounds on the left
abdominal region. Colic duration prior to referral ranged
from 4 hours to 2 days, (median 1 day). All horses recovered
from impaction within 12 hours to 6 days, (median 2 days).
During treatment the horses were muzzled, stabled on wood-
chip bedding, withheld from feed but had free access to
water. Pain was controlled by using 20 mg Metamizol/kg b.w.
or 1.1 mg Flunixin meglumine/kg b.w. two times a day i.v.
The laxative sodium sulphate solution (140 g/10 L water/500
kg b.w.) was administered via nasogastric tube daily.
The laboratory results of leucocytes, erythrocytes and total
protein were 6.9±1.3 G/l, 6.6±1.3 T/l, 65.3±0.6 g/l
respectively in horses with left ventral colon impaction at
admission, which were within normal range. 
6
In protocol A serum FFA concentration decreased significant-
ly 5 hours after feeding compared to the value before fee-
ding. There were no changes of serum triglycerides and total
bilirubin concentrations (table 1). In protocol B only FFAs con-
centration was significantly higher in comparison to the value
in protocol A before feeding (table 2). At admission serum
FFAs (12/12 horses) and total bilirubin (11/12 horses) con-
centrations were significantly elevated while serum triglyceri-
de did not differ significantly in comparison with normal hor-
ses in protocol A before feeding. Serum triglycerides measu-
red after impaction resolution were significantly higher com-
pared with values at admission. Serum FFAs and total biliru-
bin did not differ significantly at admission and after impac-
tion resolution (table 3). 
7/12 and 6/12 horses with impaction had normal values of
triglycerides and FFAs respectively after resolving impaction.
The decrease of FFAs and triglycerides correlated significant-
ly (r = 0.87). Total bilirubin was still increased in 9/12 hor-
ses when the impaction was resolved. All colic horses were
discharged one to two days (median 2 days) after impaction
resolution.
Discussion
Disturbances of lipid metabolism that result in accumulation
of serum triglycerides and FFAs associated with hyperbilirubi-
nemia are common in equine species. Severe hypertriglyceri-
demia (6.17 – 18.29 mmol/l) occurs commonly in very sick
inappetent horses (Dunkel and McKenzie 2003). Based on
N. Gomaa et al.
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the normal leucocytes counts horses of our study had left ven-
tral colon impaction but had no systemic inflammation. The-
se horses had only a mild elevation of serum triglyceride con-
centration (1.59 mmol/l) at the time of impaction resolution.
In comparison with reported reference range (<1.13 mmol/l)
the measured triglyceride concentration of these colic horses
was slightly out of range (Naylor et al 1980). This elevated tri-
glyceride concentration could be caused by overwhelming of
clearance mechanisms (Hughes et al. 2004). There was a
moderate elevation of serum FFAs measured at admission
and after impaction resolution. The reason of the elevation of
triglycerides and FFAs could be the increase of catecholami-
ne and cortisol in response to anorexia and pain in colic hor-
ses (Hinchcliff et al. 2005). Cortisol and catecholamine sti-
mulate hormone sensitive lipase and reduce the efficiency of
circulating insulin (Jaworski et al 2007). The indirect bilirubin
could be competed by higher concentrated FFAs in the serum
on hepatic carrier-mediator leading to an increase of serum
total bilirubin (Gronwall and Mia 1972). Based on this patho-
physiological mechanism the horses with impaction had
increased total bilirubin at admission and after impaction
resolution. 
The normal serum triglyceride and elevated FFA concentra-
tions measured at admission in horses with a colic duration of
one day (median) could be comparable to the values found in
unfed horses stabled without bedding (protocol B). In contrast
unfed horses with bedding had lower values of FFAs (protocol
A). These horses were able to have a straw intake during the
night. The lower digestible energy of straw could stabilize the
fat metabolism to prevent the increase of FFAs in the serum.
Table 1 Protocol A: Six clinically healthy horses stabled overnight on straw-bedded boxes without feed for 12 hours. Triglycerides (TG), free
fatty acids (FFAs) and total bilirubin were measured at 7.00 a.m before feeding and 4 times hourly. Using median, minimum (min.), and maxi-
mum (max.). Significant differences (P ≤ 0.05) are signed with stars. (a) Naylor 1983, (b) Schäfer 1999
 TG (mmol/l) 
median (min-max) 
FFAs (µmol/l) 
median (min-max) 
Total bilirubin  (µmol/l) 
median (mini-max) 
Reference ranges <1.13 mmol/l (a) 100-300 µmol/l (b) <47.8 µmol/l (b) 
Blood was collected at 7.00 a.m. before feeding 0.45 (0.30-0.57) 129.50* (67.5-170) 22.55 (17.13-34.25) 
2 hr. after feeding 0.47 (0.26-0.69) 65 (49-109) 23 (13.6-39) 
3 hr. after feeding  0.42 (0.24- 0.71) 67.5 (43-87) 22 (14.4-38) 
4 hr. after feeding  0.43 (0.28-0.76) 56 (46-157) 22.5 (14.5-41) 
5 hr. after feeding  0.46 (0.36-0.64) 47* ( 42-77.25) 21.80 (17.13-34.25) 
Table 2 Protocol B: Six clinically healthy horses stabled overnight on unbedded boxes without feed for 12 hours. Triglycerides (TG), free fatty
acids (FFAs) and total bilirubin were measured at 7.00 a.m. Using median, minimum (min.), and maximum (max.).
 TG (mmol/l) 
median (min-max) 
FFAs (µmol/l) 
median (min-max) 
Total bilirubin (µmol/l) 
median (min-max) 
Blood was collected at 7.00 a.m. before feeding 0.31 (0.23-0.38) 395.50 (292.75-520) 27.15 (21.38-29.93) 
 at admission after impaction resolution 
 
TG 
mmol/l 
FFAs 
µmol/l 
Total bilirubin 
µmol/l 
TG 
mmol/l 
FFAs 
µmol/l 
Total bilirubin 
µmol/l 
median 0.46* 830.3 75.94 1.59* 553.45 92.97 
min. 0.14 424 37.10 0.20 34 32 
max. 1.25 1441 125.10 3.83 1638 165 
Table 3 Triglycerides (TG), free fatty acids (FFAs) and total bilirubin of 12 horses with left ventral colon impaction at admission and after impac-
tion resolution. Significant differences (P ≤ 0.05) are signed with stars.
7
The elevated level of FFAs might be attributed by inappetence
in horses which suffered from impaction. These colic horses
had neither feed nor straw-bedding intake before admission.
Gronwall and Mia 1972 reported that serum triglycerides
increased only after 40 hours of feed deprivation while total
bilirubin rose after 18 hours of fasting. At admission the nor-
mal level of triglycerides in our colic horses could be associa-
ted with a shorter period of inappetence during colic. On the
other hand the total bilirubin in 11/12 horses with impaction
was elevated because inappetence during colic lasted longer
than 18 hours. This is similar to hyperbilirubinemia in fasting
horses described by Engelking 1993.
After impaction resolution serum triglycerides and FFAs of
58.3 % and 50 %  of horses returned to normal ranges. Whi-
le only 25 % of colic horses had normal values of total bili-
rubin. The FFA concentration decreased 40 % after feeding
started (Gronwall and Engelking 1982). But triglycerides and
total bilirubin return to normal values in fed horses within 2 to
7 days (Dunkel and McKenzie 2003). 
We conclude that horses with left ventral colon impaction
were exposed to fat mobilisation by inappetence or withhol-
ding of feed and pain during colic and treatment period. It is
characterised by mild increase of triglycerides, FFAs and total
bilirubin. This mild hypertriglyceridemia is reversible after fee-
ding.
We recommend that horses with impaction and/or increased
serum triglyceride level >2.26 mmol/l (Naylor et al 1980)
during a prolonged treatment period more than two days
should get partial parenteral nutrition. For example: mixture
of 4 L glucose solution 40 % and 6 L saline solution i.v. daily
for a horse with 500 kg b.w. (Schusser 1996). The parenteral
nutrition reduces lipolysis which could enhance the release of
pro-inflammatory cytokines from adipose tissue (Vick et al.
2007). Further studies are needed on fat mobilisation and
releasing of inflammatory cytokines in colic horses with lam-
initis, thrombophlebitis, paralytic ileus, peritonitis and wound
healing problems of surgical cases. 
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Abstract 
Objectives - Assaying serum alcohol dehydrogenase (ADH) activity in horses with acute 
intestinal obstruction and determining whether its level has a diagnostic or a prognostic value.  
Design – Prospective study  
Setting – University Veterinary Hospital. 
Animals – A control group (30 healthy horses) and 77 horses with acute intestinal obstruction 
(inclusion criteria) were divided into 36 with non-strangulation obstruction (23 with left ventral 
colon impaction and 13 with left dorsal displacement; (G1), 22 with small intestinal 
strangulation; (G2), and 19 with colon torsion; (G3).  
Interventions – Serum ADH activity was assayed spectrophotometerically in all horses. Serum 
lactate concentration and hepatic enzymes (AST, GGT, GLDH) activities were measured using 
an automatic analyzer. The data was statistically analyzed using software packages.  
Results – Serum ADH activity in healthy horses was 10.5 [8.7–11 U/l], median [interquartile 
range]. It was significantly increased (p < 0.05) in G1= 16.5 [13.8–18 U/l], G2= 40 [20–74.9 
U/l] and G3= 63.2 [40–78 U/l]. AST and GLDH were significantly increased in G3. There was a 
significant correlation (p < 0.01, r=0.55, r=0.8) between ADH activity and lactate concentration 
in G1 and G3 respectively. Other liver enzymes did not show any significant correlation with 
lactate. ADH activity was associated directly with the probability of strangulation; OR=1.11. 
ADH activity > 20 U/l had 80.56 % specificity and 80.49 % sensitivity for discriminating horses 
with strangulation obstruction. The outcome in horses with strangulating obstruction was divided 
into survivors and non-survivors. Twelve horses euthanized before surgery were excluded from 
the outcome. Increasing ADH activity was associated with non-survival; OR=1.03. ADH 
activity < 80 U/l had 94.44 % specificity and 66.67 % sensitivity of survival.  
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Conclusion – Serum ADH activity could have a useful clinical value in detecting the intestinal 
strangulation and predicting the prognosis in horses with acute intestinal obstruction.  
Keywords: Alcohol dehydrogenase (ADH), acute intestinal obstruction, horses 
Introduction  
Acute intestinal obstruction is the most common cause of colic in horses referred to animal 
hospitals.1 It can vary from a simple obstruction to a life-threatening strangulation obstruction. It 
is often difficult to reach a final definitive diagnosis without an exploratory laparotomy, but 
clinicians should attempt to provide owners with all possible complications and prognosis. 
Despite evidence of improved survival rates in colic surgeries, mortality is still high in horses 
with strangulating lesions.2 Mortality is usually due to acute circulatory failure secondary to 
intestinal ischemia or due to postoperative complications associated with primary lesion.3 
 Intestinal ischemia has been implicated as a prime mechanism in the pathogenesis of multiple 
organ failure and in initiating remote organ failure.4 Necrosis of intestinal mucosa and loss of 
intestinal epithelial barrier permit the resorption of bacterial toxins especially endotoxins which 
activate endothelial cells, monocytes and granulocytes in the peripheral blood system and 
Kupffer cells in the hepatic sinusoids.5,6 The activated Kupffer cells act as potent producers of 
superoxides and inflammatory cytokines such as TNF-alpha which implicate in the pathway 
leading to hepatic injury.6 Additionally, the activated leukocytes and endothelial cells adhesion 
molecules promote leukocyte adhesion and sequestration in hepatic circulation (midzone and 
pericentral sinusoids) resulting in hepatic hypoxia.7,8 Although there are several reports in the 
literature which described liver injury associated with occlusion of the superior mesenteric artery 
for 45-60 min followed by reperfusion, the lack of an early discriminating hepatic function test 
delays recognition of hepatic injury.9-11 
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Alcohol dehydrogenase (ADH) is a cytosolic oxidoreductase which is found in all mammalian 
tissues but it is abundant in centrilobular region of the liver acinus.12,13 The mammalian alcohol 
dehydrogenases are divided into six classes (ADH1–ADH6), which are further sub-divided into 
sub-groups of isoenzymes.14 In horses, there are five isoenzymes of ADH: three correspond to 
class I, a single form of class II and another of class III which is widely distributed in all tissues. 
Class I and II are found predominantly in the liver.15 
ADH is able to catalyze the reversible oxidation of steroids, lipid peroxidation products, 
retinoids and endogenous alcohols to the corresponding aldehydes. Therefore, it has been 
suggested that it plays a role in cellular detoxification mechanisms.16 Since ADH is a cytosolic 
liver enzyme with the smallest molecular weight, it is detected in blood much earlier than the 
other liver enzymes.17 Hence, serum ADH is considered a more sensitive biochemical indicator 
of hepatocellular injury due to hepatic hypoxia in comparison to hepatic transaminases.18,19  
In addition, it has been reported that endotoxemia occurring during intestinal ischemia is 
involved in the up-regulation of ADH transcriptional activity in the liver.20 Recently, it was 
reported that ADH could be a marker of intestinal ischemia which was observed in experimental 
rat model after occlusion of superior mesenteric artery for one hour.21 
The present study aims to evaluate the ADH activity in serum of horses with acute intestinal 
obstruction and determine if it could have a diagnostic or a prognostic value in horses with 
strangulating obstruction. 
Material and Methods 
Horses  
A control group consisted of 30 healthy warmblood horses were used for determination of 
normal range of serum ADH activity. They were 12 mares, 17 geldings and 1 stallion and their 
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age ranged from 5 to 25 years (median 16 years). They belonged to the veterinary teaching 
hospital, as well as a riding school which referred the horses to the animal hospital for a routine 
clinical examination. The horses were selected based on their normal demeanor, physical and 
clinicopathological parameters. They were kept in individual boxes with straw bedding and fed 
grass hay and concentrate twice a day to meet all nutritional requirements with free access to 
water. 
The horses included in this study were admitted to the veterinary teaching hospital between April 
2008 and February 2010 with signs of colic. They were clinically examined, immediately on 
arrival at the hospital, according to the protocol of colic examination.22 Only horses diagnosed 
with acute intestinal obstruction were included in this study. Based on rectal palpation and 
abdominal ultrasound examination, together with physical and clinicopathological findings, the 
horses were diagnosed with impaction in left ventral colon, left dorsal displacement of ascending 
colon, small intestinal strangulation and colon torsion. Left ventral colon impaction was 
diagnosed when doughy contents were palpated as a cone-formed end at the pelvic flexure and 
the two free taenia of the ventral large colon can be felt, separated by 90 degrees in relation to 
the circumference of the colon without significant abnormalities were noted on abdominal 
ultrasound. Left dorsal colon displacement with nephrosplenic entrapment was diagnosed when 
the taenia of the large colon was palpated crossing dorsally to the nephrosplenic ligament and 
spleen was displaced ventrally on rectal palpation; the left kidney could not be identified 
adjacent to spleen on abdominal ultrasound. Small intestinal strangulation was diagnosed when 
several distended loops of small intestine were palpated by rectal examination or seen on 
abdominal ultrasound. However, extreme distension of the large colon with gas and tremendous 
tension on its taenias were the most characteristic rectal findings in horses with colon torsion.23,24  
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The horses were treated medically, surgically or were euthanized according to the preliminary 
presumptive diagnosis of the clinician or the clinical condition of each case during or after 
surgery. In 77 horses diagnosed with acute intestinal obstruction, demographic data such as age, 
sex, and breed were recorded. They were divided retrospectively into 3 groups depending on 
clinical and surgical or pathological findings. Group 1 (non-strangulation obstruction) included 
36 horses (23 with left ventral colon impaction and 13 with left dorsal displacement of the 
ascending colon). Group 2 (small intestinal strangulation) included 22 horses (7 with 
pedunculated lipoma, 6 with inguinal hernia, 3 with omental hernia, 3 with intestinal volvulus, 2 
with small intestinal incarceration in the epiploic foramen, and one with an entrapment in a 
mesocolon rent), while group 3 included 19 horses with large colon strangulation (10 with large 
colon torsion ≥ 360° and 9 with large colon torsion < 360°). We secured the permission of the 
owners on admission to include clinical and clinicopathological results in this study.  
Blood samples 
The blood sampling was approved by the Veterinary Trial Commission, Germany. Blood 
samples were taken immediately after admission and before treatment from the jugular vein of 
all horses in the control group and in the groups with acute intestinal obstruction. Blood was 
collected in EDTA tubes for PCV, total and differential leukocytes count using an automatic 
hematology analyzer.a Tubes without anticoagulant were used for serum preparation. After 30 
min of blood collection, serum samples were prepared by centrifugation of blood at 450 x g for 
10 min. The serum sample was stored frozen at –70 °C until analyzed for maintaining the 
stability of ADH activity in serum.18 The serum samples of control group were firstly analysed in 
a batch and the serum of each group of horses with intestinal obstruction were separately 
analyzed later.  
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Method of assaying total ADH activity in serum 
ADH activity was assayed in serum using a spectrophotometerb based on the previous described 
methods for assaying serum ADH in human with some modifications.18,25 The measurement of 
ADH activity was based on the catalytic activity of ADH in the conversion of ethanol to 
acetaldehyde with simultaneous reduction of NAD+ (Nicotinamide Adenine Dinuclotide, 
oxidized form) to NADH (Nicotinamide Adenine Dinuclotide, reduced form).  
 The reagents included 100 mmol/l Glycine/NaOH-buffer in pH 10, 5 mmol/l of freshly prepared 
NAD solution (0.5 mg NAD c /50 µl distilled water), freshly prepared ADH solution (0.01 mg 
ADH d /1 ml Na phosphate buffer in pH 8) and Bovine serum albumin solution (1mg BSA g  /1ml 
Na phosphate buffer in pH 8) .   
Procedure: Six cuvettes were set up at a time, all of which contained 400 µl Glycerin/NaOH 
buffer with 0.8 µl ethanol, and 100 µl NAD solution. Two undiluted serum samples (100 µl) in 
duplicate were added to four of the cuvettes, for estimation of ADH activity. The other two were 
positive and negative controls, containing 100 µl ADH or bovine serum albumin solutions 
respectively. The spectrophotometer was prepared at 37 °C, 340 nm wavelength, and a 300-
second incubation time.  
In order to check the linearity of the method over the entire range of values, a standard curve was 
obtained for serial dilutions of ADH from 0.05 to 2 µg/ml. The assay was linear up to 151 U/l 
with R2 = 0.9992 (Fig 1). 
Additionally, the precision and reproducibility of the method was assessed in 6 positive control 
samples measured ten times and calculated the intra-assay coefficient of variation which ranged 
from 3.2 to 5.5 %. 
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Serum lactate concentration, aspartate-aminotransferase (AST), gamma-glutamyl-transferase 
(GGT) and glutamate dehydrogenase (GLDH) activities were measured using specific kitsf and 
an automatic analyzer.g    
Statistical analysis 
Data was analyzed using a statistical software package.h Testing the normality of distribution 
using Shapiro-Wilk test indicated that the data were not normally distributed. Nonparametric 
descriptive statistics were presented as median and 25th – 75th percentiles. For comparison 
between all groups of horses with acute intestinal obstruction and control group, the Kruskal-
Wallis One-Way Analysis of Variance (ANOVA) test was used followed by All Pairwise 
Multiple Comparison procedure (Dunn's Method). The Spearman’s test was used for measuring 
the correlation between ADH activity, lactate concentration and the other liver enzyme activities. 
Twelve horses with small intestinal strangulation or colon torsion that were euthanized before 
surgery on the request of the owner, due to economic reasons, were excluded from analysis of 
outcome. The outcome in 29 horses with strangulating obstruction was categorized into 
survivors and non-survivors to hospital discharge. The Mann-Whitney-U-test was used to 
compare serum ADH activity between survivors and non-survivors. Logistic regression analysis 
was used to evaluate the association between ADH activity and the probability that a horse had 
strangulating obstruction. Logistic regression analysis was also used to model the relationship 
between ADH activity as an independent factor and non- survival in horses with strangulation 
obstruction. ADH activity was considered as a potential risk factor for non-survival when 
likelihood ratio (LR) P-value was < 0.2 and odds ratio (OR) was >1. Hosmer-Lemeshow test 
with p > 0.05 consider adequate fit model. The logistic equation was used to calculate the 
probability of non-survival based on ADH activity to generate a probability curve of non-
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survival. A software packagei was used for constructing Receiver Operating Characteristics 
(ROC) curve and determining the optimal cut-off value that discriminate horses with 
strangulating obstruction from non-strangulating obstruction. The same software packagei was 
used for determining the optimal cut-off value that discriminate non-survivors from survivors in 
horses with strangulating obstruction. Specificity, sensitivity, positive and negative predictive 
value of the selected cut-off values were evaluated at 95 % confidence interval (CI). The validity 
of the selected cut-off values was equivalent to the area under curve (AUC). Statistical, AUC 
greater than 0.7 indicates a useful test.26 Significance was accepted at p ≤ 0.05.  
Results  
Of 77 horses with acute intestinal obstruction included in this study, 48 were mares, 20 were 
geldings, and 9 were stallions. Their ages ranged from 2 to 30 years (median 10 years). They 
were of various breeds (52 Warmbloods, 11 ponies, 4 Draught horses, 3 Haflingers, 3 Arabian 
horses, 2 Friesians, one Thoroughbred horse and one Icelandic horse). 
In groups 2 and 3, there was a significant (p < 0.05) increase of the heart and respiratory rates in 
comparison to the control group (Table 1). Despite the rectal body temperature did not differ 
significantly between all groups of horses, 10 horses in groups 2 and 3 showed hyperthermia 
(> 38°) and 8 horses in the same groups showed hypothermia (< 37°).  
The hematological parameters such as PCV, total and differential leukocyte counts (e.g. 
segmented and band neutrophils) were summarized as median and (25th – 75th percentile) in table 
1. There was a significant (p < 0.05) increase in PCV, total and differential leukocyte counts in 
horses with strangulating obstruction (groups 2 and 3) in comparison to non-strangulating 
obstruction (group 1) or control group. There was leucocytosis and neutrophilia with left shift 
(leukocyte count > 10 x 109 /l, segmented neutrophils > 70%, band neutrophils > 2%)27 in 9 
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horses from groups 2 and 3. On the contrary, leucopoenia and neutropenia with toxic 
granulocytes changes (leukocyte count < 5 x 109 /l, segmented neutrophils < 45%)27 were found 
in 4 horses from the same groups. 
The serum activities of ADH, AST, GGT, GLDH and lactate concentrations were listed in table 
2. Median serum ADH activity in the control group was 10.5 [8.7–11 U/l]. It was highly 
significant (p < 0.01) increased in horses with small intestinal strangulation (group 2) and horses 
with colon torsion (group 3), median 40 [20–74.9 U/l] and 63.2 [40–78 U/l] respectively. Serum 
ADH activity in horses with non-strangulation obstruction (group 1) was significantly lower (p < 
0.05; median 16.6 [13.8–18] U/l) than in horses in group 2 and 3, but still higher (p < 0.05) than 
the control group. Nevertheless, there was no significant difference in serum ADH activity 
between horses with small intestinal strangulation and colon torsion.  
Serum AST and GLDH activities were only significantly increased in group 3 in comparison to 
the control group or group 1. However, serum GGT activity did not show any significant 
differences in all groups of horses with acute intestinal obstruction in comparison to the control 
group (Table 2).  
The serum lactate concentrations were significantly increased in all groups of horses with acute 
intestinal obstruction (Table 2). In particular, the greatest median value was observed in horses 
with colon torsion (7.4 mmol/l). 
There was a strong positive correlation (p < 0.01, r = 0.55, r = 0.8) between ADH activities and 
lactate concentrations in groups 1 and 3 respectively. However, there was no significant 
correlation between the other liver enzymes activities and lactate concentrations in all groups of 
horses. 
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The presence of a linear association between increasing ADH activity and the probability for 
strangulation obstruction was found, OR= 1.11; 95% CI [1.05– 1.17].  
The selected cut-off values of serum ADH activity that distinguish between horses with 
strangulating obstruction (41 horses with small intestinal strangulation and colon torsion) and 
non-strangulating obstruction (36 horses with impaction in left ventral colon and left dorsal 
displacement) were displayed in table 3. Receiver operating characteristics (ROC) curve for 
sensitivity and 1-specificity of these cut-off values indicated their high performance in 
differentiation between horses with strangulating obstruction and non-strangulating obstruction 
(Fig 2). It was confirmed by the area under curve, AUC = 0.86; 95 % CI (0.817 – 0.903). It was 
seen that serum ADH activity at 20 U/l is the optimal cut-off that yields the highest specificity of 
80.6 % and sensitivity of 80.5 % for the test. All horses with non-strangulating obstruction had 
serum ADH activity lower than 20 U/l except 5 horses had serum ADH activity greater than 20 
U/l (false positive) with 82.5 % of positive predictive value. Three of them with impaction in left 
ventral colon and pelvic flexure and 2 with left dorsal displacement with secondary impaction of 
the ascending colon had serum ADH activity between 30 – 42 U/l. 
On contrast, all horses with strangulating obstruction had serum ADH activity greater than 20 
U/l except 6 horses had ADH activity lower than 20 U/l (false negative) with 78.4% negative 
predictive value. Four of them had inguinal hernia, one had omental hernia and one had colon 
torsion < 360°. 
All horses with non-strangulation obstruction were medically treated and discharged from 
hospital without signs of colic. Twelve horses with strangulation obstruction in groups 2 and 3 
that were euthanized before surgical operation for economic reasons were excluded from 
analysis of outcome. The outcome in horses with strangulating obstruction was classified into 
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survivors, seventeen horses survived to hospital discharge and non-survivors, twelve horses 
failed to survive to hospital discharge. Three of them died after admission secondary to acute 
circulatory failure (shock). However, 5 horses were euthanized intraoperatively because of 
extensive intestinal necrosis which assessed clinically at time of surgery by using scoring system 
based on morphological alterations28 (serosal and mucosal dark colour, oedema, looseness of 
tissue and hemorrhagic infarction). Another 4 horses were euthanized after surgery due to 
deterioration of the general circulation or postoperative complications as paralytic ileus, 
peritonitis and colitis (Table 4). Although the euthanasia is not the outcome, it was done because 
of inability of saving the animal’s life or due to postoperative complications which interfere with 
the quality of animal’s life. 
Increased ADH activity was associated with non-survival in horses with strangulating 
obstruction which indicated by OR= 1.03 %, 95% CI (1.005–1.058 %). The logistic regression 
model fits the data well as Hosmer-Lemeshow test had P-value= 0.31. By evaluating the 
inflection point on the probability curve of non-survivor, it was noticed that the probability of 
non-survival increased considerably when ADH activity >80 U/l (Fig 3).  
The selected cut-off values for determining the outcome in horses with strangulating obstruction 
indicated high performance in differentiating between survivors and non-survivors, AUC = 0.84; 
95 % CI (0.76 – 0.91), (Fig 4).  
In table 5, it was seen that serum ADH activity at 70 and 80 U/l yielded the same sensitivity as 
there was no non-survivor with ADH activity between 70 and 80 U/l. Nevertheless, the 
specificity, positive and negative predictive value increased at 80 U/l. Therefore, the ADH 
activity at 80 U/l seems to be the optimal cut-off that minimizes the specificity and sensitivity of 
the test.  
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The horses with ADH activity greater than 80 U/l were classified as non-survivors except one 
horse which survived after surgery and had ADH activity greater than 80 U/l. Therefore, ADH 
activity > 80 U/l had 88.9 % positive predictive value for predicting the non-survival in horses 
with strangulating obstruction. In contrast, all horses that underwent the surgery and had ADH 
activity less than 80 U/l survived to hospital discharge except 4 horses with ADH activity less 
than 80 U/l failed to survive to hospital discharge. Three of them were euthanized 
postoperatively due to postoperative complications and one was euthanized intra-operatively; 
hence, ADH activity < 80 U/l yielded 80 % negative predictive value.   
Discussion  
 In this study, the horses with small intestinal strangulation (group 2) and colon torsion (group 3) 
showed a significant increase in heart and respiratory rates as well as a significant elevation of 
PCV when compared to non-strangulation obstruction (group 1) and the control group. The 
increase of these parameters was related to the presumptive toxemia or sepsis in groups 2 and 
3.29 This also had a bearing in the decision for an emergency surgical treatment.30 There was 
leucocytosis with left shift (band cells > 2%) in most horses of groups 2 and 3 whereas others 
showing leucopoenia with toxic changes in granulocytes. This can be explained by the migration 
of leukocytes to ischemic intestine which is associated with leukocyte and endothelial cell 
activation after resorption of bacterial toxins.31 Moreover, some horses in groups 2 and 3 showed 
hyperthermia (> 38°) or hypothermia (< 37°) with significant increase in respiratory and heart 
rates. This clinical and hematological picture in horses of groups 2 and 3 hints at a systemic 
inflammatory response syndrome (SIRS) that could lead to a multiple organ dysfunction.32,33  
The present study provides a novel clinical evaluation of serum ADH activity in horses with 
acute intestinal obstruction. To our knowledge, serum ADH activity has not been reported 
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previously in horses. Therefore, a normal range of serum ADH value in healthy horses was 
established for comparison with serum ADH activity in horses with acute intestinal obstruction. 
A highly significant increase of serum ADH activity was found in horses with colon torsion 
(group 3) followed by the horses with small intestinal strangulation obstruction (group 2) and 
horses with non-strangulation obstruction. This could be attributed to several factors. First, all of 
these horses had a degree of intestinal hypoperfusion even the horses with non-strangulation 
obstruction as a result of intestinal distension due to gases or impactions.34,35 Second, the horses 
in groups 2 and 3 showed signs of SIRS as a result of presumptive endotoxemia as discussed 
above. The increase of ADH in blood was most likely associated with endotoxemia which has a 
role in activation of ADH mRNA transcription, ADH protein and ADH activity in liver.20 Since 
the large colon in horses contains more bacterial toxins than the small intestine,36 the necrosis of 
intestinal mucosa of the large colon permits more endotoxin resorption into the blood. The toxin 
enters the systemic circulation owing to permeability changes during strangulating obstruction 
and can directly activate the neutrophils, monocytes and granulocytes.37 The activation of 
leukocytes with up-regulation of adhesion molecules on sinusoidal endothelial cells causes 
neutrophil sequestration in hepatic sinusoids and an early hepatic injury associated with ADH 
release.38 Furthermore, ADH is a natural constituent of intestinal epithelium,16 therefore, there 
was probably an additional increase in serum ADH following its release from the ischemic 
intestinal epithelium.  
On the other hand, the level of AST activity was significantly increased in horses with colon 
torsion (group 3). This increase of AST activity was similar to that previously observed in horses 
exposed to low flow ischemia in large colon.39 The increase of AST activity probably occurred 
subsequent to muscle damage from excessive pressure or hypoperfusion. However, another 
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hepatic transaminase (GGT) was not significantly increased in all groups of horses with acute 
intestinal obstruction when compared to the control group. Although the elevation of GGT 
activity was reported in horses with right dorsal displacement as a result of the compression of 
right dorsal colon on the bile duct resulting in extra-hepatic bile duct obstruction which did not 
likely occur in horses with left dorsal displacement as did in this study.40 This diversity of 
hepatic enzymes activity in the serum attributed to the zonal distribution of the various liver 
enzymes. The hepatic enzymes (AST and GGT) are distributed in the periportal region of the 
liver and are released only in case of severe hepatic damage.17 The rapid clinical course of 
intestinal ischemia may not allow time for this prominent damage in the liver and release of 
these transaminases.17,35 In contrast, ADH is a cytosolic liver enzyme which predominately 
distributed in the centrilobular (perivenous) region and released even with a mild hepatic 
injury.17 However, GLDH is the most sensitive mitochondrial liver enzyme to low hepatic 
perfusion and endotoxemia.17,36 Therefore, it was only increased significantly in group 3.  
Because most L-lactic acid is producing during the anaerobic metabolism of glucose, its level in 
blood is a good indicator of the severity of metabolic acidosis secondary to tissue 
hypoperfusion.41 The blood vessel occlusion caused by intestinal strangulation causes tissue 
hypoperfusion and subsequent production of L-lactic acid from hypoperfused tissue. The ability 
of the liver to consume lactate is concentration-dependant and progressively decreases as the 
level of blood lactate increases.42 The normal plasma L-lactate concentration in horses is 
generally considered to be <1.5 mmol/l.43  Most horses diagnosed with acute intestinal 
obstruction in this study had a significant increase of serum lactate concentration. 
Hyperlactatemia in horses (groups 2 and 3) was most likely associated with excessive production 
of L-lactic acid from hypoperfused strangulating intestine. Moreover, the distended intestine due 
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to impaction or gases is often subjected mural compression leading to a decrease in vascular 
supply.44 For this reason, there was a significant increase of serum lactate concentration in group 
1 with non-strangulation obstruction in comparison to the control group. 
The hyperlactatemia in sepsis is not usually a marker of tissue hypoperfusion more than an 
indicator of hypermetabolism.45 Sepsis-induced inflammatory mediators accelerate aerobic 
glycolysis, increasing pyruvate, inhabiting pyruvate dehydrogenase and increasing lactate.46 
Therefore, the presumptive sepsis in horses in groups 2 and 3 was suggested to be an additional 
cause of hyperlactatemia especially in horses with colon torsion. In addition, it might be an 
important contributor for the presence of positive correlation between ADH activity and lactate 
concentration in horses with colon torsion. By the same way, it can be explained the presence of 
no significant correlation between ADH and lactate in horses in group 2; in which, small 
intestine contain less amount of bacterial toxins and the presumptive toxaemia may be low in 
horses with small intestinal strangulation. Additionally, the hyperlactatemia during sepsis is not 
a consequence of liver injury or hypoperfusion.47 Therefore, there was no correlation between 
hyperlactatemia and hepatic transaminases in horses with acute intestinal obstruction.  
In the present study, ADH activity greater than 20 U/l was determined for discriminating horses 
with strangulating obstruction from non-strangulating obstruction. It gives the highest possible 
specificity and sensitivity of the test. The positive predictive value was affected by the numbers 
of the false positive (5 horses with non-strangulation obstruction had ADH activity greater than 
20 U/l) which was clinically diagnosed with impaction in pelvic flexure as well as left dorsal 
displacement with secondary impaction. The luminal narrowing of pelvic flexure with a 
prolonged time of impaction can create mural compression from intra-luminal distension, which 
in turn, could be able to reduce the local perfusion and lead to ischemia. As well as a massive 
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prolonged tight distension in ascending colon in the case of left dorsal displacement with 
secondary impaction and gas distension causes severe stretching of intestinal wall and increases 
intra-luminal pressure which could lead to mural ischemia.48 Furthermore, the negative 
predictive value could be affected by the numbers of the false negative which had inguinal 
hernia and colon torsion 180°.  In these subacute cases, there is no vascular involvement in small 
intestine or large colon.49 They were represented clinically by less severe pain and only 
moderately changes in vital signs. Additionally, during surgery, these cases did not show any 
ischemic changes in intestinal mucosa and did not require any surgical resection. 
From that, it is clear that the level of ADH activity could be affected by the degree of intestinal 
distension which consequently affect on tissue perfusion as well as it was affected by the lesion’s 
location, type and degree of intestinal strangulation.  
Giving a prognosis for horses required emergency abdominal surgery is a challenge to clinicians, 
due to the high costs of surgery and intensive care; nevertheless, it is difficult to specify because 
of multiple factors to consider, including type, location and severity of the primary lesion and the 
secondary changes complicating it.50 In this study we have attempted to evaluate the prognostic 
value of serum ADH activity in horses with strangulating obstruction without considering these 
multiple factors. Further, serum ADH activity showed a significant increase in non-survivors in 
comparison to survivors. This increase of ADH activity was associated positively with non-
survival. The power of ADH activity for discriminating the non-survivors with strangulating 
obstruction depends on the chosen cut-off value.  Although ADH activity at 70 and 80 U/l yields 
the same sensitivity, ADH activity at 80 U/l have higher specificity, positive and negative 
predictive values. It is also important to know that by choosing a lower cut-off value, thereby 
increasing the sensitivity at the expense of the specificity. This means that will be a larger 
26
  
 
number of mispredication of non-survival. Considering the economic and emotional costs 
resulting from false prediction, an optimum cut-off value which yields the highest positive and 
negative predicative values was chosen. By choosing the cut-off value at 80 U/l, only one 
survivor was misclassified as non-survivor and four non-survivors were misclassified as 
survivors. The survived horse with ADH activity 90 U/l had small intestinal incarceration in 
epiploic foramen. During surgery, there was not any detectable necrotic lesion in the 
incarcerated portion; in which only a reposition of the herniated bowel was necessary. The 
incarcerated bowel in epiploic foramen may have partially occluded the caudal vena cava and 
the hepatic portal vein resulting in decreasing venous return to heart and hepatic hypoperfusion 
which could explain the increasing ADH activity. Meanwhile the large opening of epiploic 
foramen may permit the herniated intestine to reduce easily without any strangulating lesion.51 
However, three of horses that failed to survive to hospital discharge with ADH activity less than 
80 U/l were euthanized postoperatively as a result of severe postoperative complications and one 
was euthanized intra-operatively.  
From this study, it is obvious that the level of ADH activity in serum has a potential clinical 
value in determination and prognostication strangulation obstruction in horses with acute 
intestinal obstruction. 
In term of the method of ADH assaying, it is a simple technique with the availability of an 
ordinary spectrophotometer analyzer and results can be obtained in a short period of time.  
The limitations of this study are: the general low number of horses within each final diagnostic 
category according to lesion’s type or location; thus, one prognostic cut-off value was chosen for 
both groups of horses with strangulating obstruction. However, a variety of factors could 
influence on the outcome in each group (e.g. type of lesion, its location and degree of 
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strangulation) which were not considered in this study and can indirectly affect on the 
predication of prognosis. Furthermore, it is specific population results that could vary from 
population to another according to the number of horses and the prevalence of disease in this 
population. Therefore, this study must be considered currently as a preliminary study. In the 
future, capacity of ADH activity in predication of survival should be tested against other 
variables affecting on the prognosis in a multivariate model.  
Conclusions 
Serum ADH activity is increased significantly in horses with strangulation obstruction in 
comparison to non-strangulation obstruction and its increase is associated directly with the 
probability of strangulation obstruction in horses. Additionally, increasing serum ADH activity 
is associated with non-survival in horses with strangulating obstruction. The level of ADH 
activity in serum of these horses could be useful in differentiating intestinal strangulation from 
non-strangulation obstruction which is important in guiding the treatment and determining 
prognosis where economic constraints limit surgical intervention.   
Footnotes 
a
  ADVIA 120, Bayer Diagnostics, Fernwald, Germany 
b
  Beckman Coulter DU 640B, Krefeld, Germany 
c
  Nicotinamide Adenine Dinuclotide, Sigma, Germany  
d
  Alcohol dehydrogenase from yeast, Sigma, Germany 
e
  Bovine serum albumin, Sigma, Germany  
f
  Commercial test kits from Roche and Randox Laboratories  
g
  Hitachi 912, Boehringer Mannheim, Germany  
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h
  SigmaPlot 11® Erkath, Germany 
i    Win Episcope 2.0® Zaragoza, Spain 
References  
1. Reeves JM, Salman DM, Smith G. Risk factors for equine acute abdominal disease 
(colic): results from a multi-center case–control study. Preventive veterinary Medicine 1996; 
26:285–301. 
2. Sutton GA, Ertzman-Ginsburg R, Steinman A, Milgram J. Initial investigation of 
mortality rates and prognostic indicators in horses with colic in Israel. A retrospective study. 
Equine Vet J 2009; 41(5):482–486. 
3. Mair TS, Smith LJ. Survival and complication rates in 300 horses undergoing surgical 
treatment of colic. Part 1: short-term survival following a single laporatomy. Equine Vet J 2005; 
37(4):296–302. 
4. Swank MG, Deitch AE. Role of the gut in Multiple Organ Failure: Bacterial 
translocation and permeability changes. World J Surg 1996; 20(4):411–417.  
5. Morris DD. Endotoxemia in horses. A review of cellular and humoral mediator involved 
in its pathogenesis. J Vet Intern Med 1991; 5(3):167–181. 
6. Su LG. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell 
activation. Am J physiol gastrointestinal liver physiol 2002; 283(2):G256–265. 
7. Horie Y, Wolf R, Miyasaka M, Anderson CD, Granger ND. Leukocyte adhesion and the 
hepatic microvascular responses to intestinal ischemia-reperfusion in rats. Gastroenterology 
1996; 111(3):666–673. 
29
  
 
8. Horie Y, Wolf R, Anderson CD, Granger DN. Hepatic leuokostasis and hypoxic stress in 
adhesion molecule-deficient mice after gut ischemia/reperfusion. J Clin Invest 1996; 99(4):781-
788.   
9. Poggetti RS, Moore FA, Moore EE, Koeike K, Banerjee A. Simultaneous liver and lung 
injury following gut ischemia is mediated by xanthine oxidase. J Trauma 1992; 32(6):723–728. 
10. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Banerjee A. Liver 
injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg 1992; 
127(2):175–179. 
11. Turnage RH, Bagnasco J, Berger J, Guice KS, Oldham KT, Hinshaw DB. Hepatocellular 
oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res 1991; 51(6):467–471. 
12. Sund H, Theorell H. Alcohol dehydrogenase. In: Boyer PD, Lardy H, Myrbäck K, eds. 
The Enzymes. 2nd ed.  Academic Press, New York; 1963, pp. 25. 
13. Kato S, Ishii H, Aiso S, Yamashita S, Ito D, Tsuchiya M: Histochemical and 
immunohistochemical evidence for hepatic zone 3 distribution of alcohol dehydrogenase in rats. 
Hepatology 1990; 12(1):66–69. 
14. Höög JO, Hedberg JJ, Strömberg P, Svensson S. Mammalian alcohol dehydrogenase - 
functional and structural implications. J Biomed Sci 2001; 8(1):71–76. 
15. Seeley TL, Mather PB, Holmes RS. Electrophoretic analyses of alcohol dehydrogenase, 
aldehyde dehydrogenase, aldehyde reductase, aldehyde oxidase and xanthine oxidase from horse 
tissues. Comp Biochem Physiol B 1984; 78(1):131–139. 
16. Ashmarin IP, Danilova RA, Obukhova MF, Moskvitina TA, Prosorovsky VN. Main 
ethanol metabolizing alcohol dehydrogenase (ADH I and ADH IV) biochemical function and the 
physiological manifestation. FEBS Lett 2000; 486(3):49–51.  
30
  
 
17. Parks DA, Granger DN. Ischemia - reperfusion injury: a radical view. Hepatology 1988; 
8(3):680–682.  
18. Kato S, Ishii H, Kano S, Hagihara S, Todoroki T, Nagata S, Takahashi H,  Nagasaka M, 
Sato J, Tsuchiya M. Improved assay for alcohol dehydrogenase activity in serum by centrifugal 
analysis. J. Clin Chem 1984; 30(11):1817–1820.  
19. Kato S, Ishii H, Kano S, Hagihara S, Todoroki T, Nagata S, Takahashi H, Shigeta Y, 
Tsuchiya M. Alcohol dehydrogenase: A new sensitive marker of hepatic centrolobular damage. 
Alcohol 1985; 2(1):498–501. 
20. Potter JJ, Rennie-Tankersley L, Mezey E. Endotoxin enhances liver alcohol 
dehydrogenase by action through upstream stimulatory factor but not by nuclear factor-kappa B. 
J Biol Chem 2003; 278(6):4353–4357. 
21. Gumaste UR, Joshi MM, Mourya DT, Barde PV, Shrivastav GK, Ghole VS. Alcohol 
dehydrogenase: a potential new marker for diagnosis of intestinal ischemia using rat as a model. 
World J Gastroenterol 2005; 11(6):912–916. 
22. White NA, Edwards B. Hand book of equine colic. 1st ed. Reed educational and 
professional publishing Ltd; 1999, pp. 8–39.  
23. Kopf N. Rectal examination of the colic patient. In: Robinson NE, ed. Current treatment 
in equine medicine. 2nd ed. Philadelphia: WB Saunders Co; 1987, pp. 23–27. 
24. Freeman S. Ultrasonography of the equine abdomen: findings in the colic patient. In 
Practice 2002; 24:262–273.  
25. Shephard MD, Penberthy LA, Berry MN. Adaptation of methods for glutamate 
dehydrogenase and alcohol dehydrogenase activities to a centrifugal analyser: assessment of 
their clinical use in anoxic states of the liver. J Clin Pathol 1987; 40(10):1240–1246. 
31
  
 
26. Akobeng KA. Understanding diagnostic tests 3: receiver operating characteristic curves. 
Acta Paediatr 2007; 96(5):644–647.  
27. Schäfer M. Haematological and biochemical parameters of healthy horses. In: Dietz O 
and Huskamp B, eds. Handbuch Pferdepraxis. 2nd ed. Ferdinand Enke Verlage Stuttgart; 1999, 
pp.2. 
28. Snyder JR, Olander HJ, Pascoe JR, Holland M, Kurspers-hoek CJ. Morphological 
alterations observed during experimental ischemia of equine large colon. Am J Vet Res 1988; 
49(6):801–809. 
29. Oikawa M, Yamaoka S. Clinical, haematological and biochemical analysis of 
experimental endotoxemia in Thoroughbred horses. J Equine Sci 2003; 4(1):5–12.  
30. Ihler CF, Venger JL, Skjerve E. Evaluation of clinical and laboratory variables as 
prognostic indicators in hospitalised gastrointestinal colic horses. Acta Vet Scand 2004; 45(1-
2):109–118. 
31. Southwood LL. Acute abdomen. Clinical Techniques in Equine Practice 2006; 5:112–
126. 
32. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald 
WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in 
sepsis. Chest 2009; 136(5 Suppl):1644–1655. 
33.  Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J  Clin Invest 2003; 112 (4): 
460–467.         
34. Dabareiner RM, White NA, Donaldson LL. Effects of intra-luminal distension and 
decompression on micro vascular permeability and hemodynamics of the equine jejunum. Am J 
Vet Res 2001; 62(2):225–236. 
32
  
 
35.  Snyder JR, Pascoe JR, Olander HJ, Hinds DM, Young R, Tyler WS. Vascular injury 
associated with naturally occurring strangulating obstructions of the equine large colon. Vet Surg 
1990; 19(6):446–455.  
36. Grulke S, Franck T, Gangl M, Péters F, Salciccia A, Deby-Dupont G, Serteyn D. 
Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease. 
Can J Vet Res 2008; 72(1):37–42. 
37. Benbarek H, Deby-Dupont G, Caudron I, et al. Interaction between lipopolysaccharides 
and blood factors on the stimulation of equine polymorphonuclear neutrophils. Vet Immunol 
Immunopathol 1998; 64(4):313–271. 
38. Jaeschke H and Smith CW. Cell adhesion and migration. Leukocyte adhesion and 
transmigration in the liver vasculature. Am J Physiol Gastrointest Liver Physiol 1997; 
273:G1169–G1173. 
39. Moore RM, Muir WW, Rush BR. Systemic and colonic venous plasma biochemical 
alterations in horses during low flow ischemia and reperfusion of large colon. Can J Vet Res 
1998; 62(1):14–20.   
40. Gardner RB, Nydam DV, Mohammed HO, Ducharme NG, Divers TJ. Serum gamma 
glutamyl transferase activity in horses with right or left dorsal displacements of the large colon. J 
Vet Intern Med 2005; 19(5):761–764.  
41.  Delesalle C, Dewulf J, Lefebvre RA, Schuurkes JA, Proot J, Lefere L, Deprez P. 
Determination of lactate concentrations in blood plasma and peritoneal fluid in horses with colic 
by an Accusport Analyzer. J Vet Intern Med 2007; 21(2):293–301. 
42. Kanto JJ, Harvey JW, Bruss ML. Clinical biochemistry of domestic animals. 5th Ed. 
Academic Press, San Diego, California 1997; p.932. 
33
  
 
43. Anderson MG. The effect of exercise on blood metabolite levels in the horse. Equine Vet 
J 1975; 7(1): 27–33. 
44.  Faleiros RR, Macoris DG, Alessi AC, Saquetti CH, Rasera L. Effect of intraluminal 
distension on microvascular perfusion in the equine small colon. Am J Vet Res 2002; 
63(9):1292–1297. 
45. Gore DC, Jahoor F, Hibbert J et al. Lactic acidosis during sepsis is related to increased 
pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 244(1): 97–102. 
46. De Backer D. Lactic acidosis. In: Pinsky MR, Brochard L, Mancebo J, Hedenstierna G, 
eds. Applied physiology in intensive care medicine. 2nd ed. Springer-Verlag Berlin Heidelberg 
2009; p. 89–92. 
47. De Backer D, Creteur J, Silva E, Vincent JL. The hepatosplanchnic area is not a common 
source of lactate in patient with severe sepsis. Crit Care Med 2001; 29(2):256–261. 
48. Robertson JT. Obstructive diseases In: Mansmann RA, McAllister ES, eds. Equine 
medicine and surgery. 3rd ed. Santa Barbara: Veterinary publication; 1982, p. 559–579. 
49. Radostits OM, Gay CC, Blood DC, Hinchcliff KW. Diseases of the non-ruminant 
stomach and intestine. Equine colic. In: Veterinary medicine: text book of the disease of cattle, 
sheep, pig, goats and horses. 8th ed. WB Saunders; 1999; p. 197-247. 
50. Huskamp B. Ileus diagnosis in horse. Tierarztl Prax 1973; 1(1):67–74. 
51. Vasey JR. Incarceration of the small intestine by epiploic foramen in fifteen horses. Can 
Vet J 1988; 29(4):378–382. 
 
34
  
 
 
 
Table 1: Physical and hematological parameters in normal horses (control 
group) and horses with acute intestinal obstruction (group 1: horses with non-
strangulating obstruction, group 2; horses with small intestinal strangulation 
and group 3; horses with colon torsion).  
 
 
 
 
* Significant higher than values of the control group and group 1 (p ≤ 0.05). 
§ n= number of horses in each group 
 
The results represented as median (25th – 75th quartiles) 
 Control group 
 
 
§ (n = 30) 
Non strangulation 
obstruction 
group 1 
§ (n = 36) 
Small intestinal 
strangulation 
group 2  
§ (n = 22) 
Colon torsion 
 
group 3 
§ (n = 19) 
Rectal temp. 37.5 (37.2 – 37.9) 37.8 (37.4 – 38.2) 37.7 (36.6 – 39.1) 37.6 (37 – 38.9) 
Heart rate/min 34 (30 – 38) 44 (38 – 51) 66 (48 – 80)* 80 (68 – 80)* 
Resp. rate/min 14 (12 – 16) 16 (14.3 – 24) 33 (30 – 40)* 47  (41 – 49)* 
PCV l/l  0.32 (0.3 – 0.4) 0.3 (0.27 – 0.31) 0.4 (0.3 – 0.4)* 0.5 (0.4 – 0.6)* 
Leucocyte (x 109/l) 7 (5 – 8) 8.2 (5.7 – 8.6) 9.2 (4.7 – 10.3)* 10.4 (6.8 – 13)* 
Segm. Neutro(x 109/l) 4.5 (2.6 – 6.1) 5.9 (3.2 – 6.5) 6.5 (2.2 – 8.6) * 8.4 (4.2 – 11.5) * 
Segm. Neutro % 64 (52 – 75) 61 (56 – 75)  71 (52 – 83) * 80 ( 62 – 88) * 
Bands  (x 109/l) 0 (0 –  0.1) 0 (0 –  0.1) 0.19 (0 – 0.8) * 0.5 (0.2 – 0.7) * 
Bands % 0 (0  – 1) 0 (0 –  1) 3.5 (0 – 11) * 4 (2 –  9.2) * 
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Table 2: Clinical chemistry parameters of normal horses (control group) and 
horses with acute intestinal obstruction (group 1: horses with non-strangulating 
obstruction, group 2; horses with small intestinal strangulation and group 3; 
horses with colon torsion).  
 
 
 
 
 
Control group 
 
 
§ (n = 30) 
Non strangulation 
obstruction 
Group 1 
§ (n = 36) 
Small intestinal 
strangulation 
Group 2 
§ (n = 22) 
Colon torsion 
 
Group 3 
§ (n = 19) 
ADH U/l   10.5 (8.7 – 11)    16.6 (13.8 – 18)* 40 (20 – 74.9)*  63.2 (40 – 78)*  
AST U/l 328 (289.5 –  422) 342.5 (299.5 – 423) 368.3 (271– 542.3) 530 (414 – 630.5) * 
GGT U/l 19 (14.9 – 26.5)    17 (11.3 – 48.6) 22.2 (15.9 – 39.8) 36 (16.3– 55) 
GLDH U/l     2.5 (1.9 – 5.7)      4.7 (2.5 – 12.4) 5.9 (2.5 – 10.7) 59.5 (6.6 – 197.8)* 
Lactate mmol/l     0.9 (0.8 – 1.1)      1.8 (1.5 – 2.2)* 3.7 (3.1 – 11.6)* 7.4 (2.5 – 15.7)* 
* Significant higher than values of the control group (p ≤ 0.05). 
§ n= number of horses in each group 
 
The results represented as median (25th – 75th quartiles) 
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Table 3: The cut-off values of serum ADH activity (U/l) differentiate between 
horses with strangulating obstruction (41 horses) and horses with non-
strangulating obstruction (36 horses). 
Cut-off value 10 20 30 40 50 
‡ SO/NSO 41/2 33/29 29/32 24/34 19/36 
Sensitivity 
CI% 
100 
(100 – 100) 
80.5 
(68.4 –  92.6) 
70.7 
(56.8 –  84.7) 
58.5 
(43.5 – 73.6) 
46.3 
(31.1 – 61.6) 
Specificity 
CI% 
5.6 
(0 – 13) 
80.6 
(67.6 – 93.5) 
88.9 
(82.64 – 100) 
94.4 
(86.9 – 100) 
100 
(100 – 100) 
Positive predictive value 
CI% 
54.7 
(43.4 – 65.9) 
82.5 
(70.7 – 94.3) 
87.9 
(76.7 – 99) 
92.3 
(82.1 – 100) 
100 
(100 – 100) 
Negative predictive value 
CI% 
100 
(100 – 100) 
78.4 
(65.1 – 91.6) 
72.7 
(59.6 – 85.9) 
66.7 
(53.7 – 79.6) 
62 
(49.6 – 74.6) 
 
 
‡ SO= number of horses with strangulation obstruction and ADH activity greater than the 
corresponding cut-off value (True positive). 
‡ NSO= number of horses with non-strangulating obstruction and ADH activity lower than the 
corresponding cut-off value (True negative). 
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Table 4:  Surgical and pathological findings as well as ADH activity in 
survivors (17 horses) and non-survivors (12 horses) with strangulating 
obstruction in groups 2 and 3. 
 
 
 
 
 
Survivors Non-survivors 
Lesion ADH 
U/l 
Lesion ADH 
U/l 
Survived 
Inguinal hernia 
 
20 
Died 
Pedunculated lipoma 
 
105 
Inguinal hernia 17 Entrapment in mesocolon rent  124 
Inguinal hernia 16 Colon torsion ≥ 360° 166 
 Euthanized intraoperatively 
Inguinal hernia 13.7 Pedunculated lipoma 88.4 
Inguinal hernia 17.4 Colon torsion ≥ 360° 86 
Inguinal hernia 50 Colon torsion ≥ 360° 94 
Pedunculated lipoma 27.9 Colon torsion ≥ 360° 122.8 
Omental hernia 18.5 Colon torsion ≥ 360° 62.1 
Epiplotic hernia 90 Euthanized postoperatively           
Colon torsion < 360° 13 volvolus 21.5 
Colon torsion < 360° 34.9 Pedunculated lipoma  22 
Colon torsion < 360° 47.7 Omental hernia 86.5 
Colon torsion ≥ 360° 71.1 Colon torsion ≥ 360° 38.4 
Colon torsion ≥ 360° 58   
Colon torsion ≥ 360° 68.5   
Colon torsion ≥ 360° 64.2   
Mesenteric and colonic torsion 56   
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Table 5: The cut-off values of ADH activity in serum (U/l) differentiate 
between survivors (17 horses) and non-survivors (12 horses) in horses with 
strangulating obstruction in groups 2 and 3. 
 
Cut-off value 50 60 70 80 90 
‡ NS/S 9/10 9/13 8/15 8/16 5/17 
Sensitivity 
CI% 
75 
(50.5 – 99.5) 
75 
(50.5 –  99.5) 
66.7 
(39.9 – 93.3) 
66.7 
(39.9 – 93.3) 
41.7 
(13.7 – 69.6) 
Specificity 
CI% 
58.8 
(42 – 87.4) 
76.5 
(51.5 – 96.9) 
88.2 
(72.9 – 100) 
94.4 
(83.9 – 100) 
100 
(100 – 100) 
Positive predictive value 
CI% 
56.3 
(35.2 – 84.8) 
69.2 
(44.1 –  94.3) 
80 
(55.2 – 100) 
88.9 
(68.4 – 100) 
100 
(100 – 100) 
Negative predictive value 
CI% 
76.9 
(57.1 – 100) 
81.3 
(62.1 – 100) 
79 
(60.6 – 97.3) 
80 
(62.5 – 97.5) 
70.8 
(52.7 – 89) 
 
‡ NS= number of non-survivors with ADH activity greater than the corresponding cut-off value 
(True positive). 
‡ S= number of survivors with ADH activity lower than the corresponding cut-off value (True 
negative). 
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Figure 1: The linearity of ADH activity was observed in the obtained standard curve of assaying 
ADH activity at different concentrations.  
 
Figure 2: The ROC curve shows the association between cut-off values of ADH activity that 
differentiating between horses with strangulation obstruction and horses with non-strangulation 
obstruction, sensitivity and 1-specificty. The optimal cut-off value is located closest to the upper 
left corner. At this cut-off (20 U/l), the sensitivity is 80.5% and specificity is 80.6%. 
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Figure 3: Probability curve for non-survival in horses with strangulation obstruction versus 
serum ADH activity as an independent factor. The inflection point at 80 U/l indicated that the 
probability of non-survival increased considerably when ADH activity ≥ 80 U/l. S.E, standard 
error of the mean.   
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Figure 4:  The ROC curve shows the association between cut-off values of ADH activity that 
distinguish the survivors from non-survivors in horses with strangulation obstruction, sensitivity 
and 1-specificty: The optimal cut-off value is located closest to the upper left corner. At this cut-
off (80 U/l), the sensitivity is 66.7% and specificity is 94.4%. 
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Results 
 
2.3 Publication 3: Effect of Buscopan® compositum on the motility of the 
duodenum, cecum and left ventral colon in healthy conscious horses 
 
Berliner und Münchener Tierärztliche Wochenschrift 2011, in press 
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Leipzig, Germany 
 
Effect of Buscopan® compositum on the Motility of the Duodenum, Cecum and Left 
Ventral Colon in Healthy Conscious Horses 
 
Wirkung von Buscopan® compositum auf die Motilität des Duodenums, Blinddarmes und der 
linken ventralen Längslage des großen Kolons bei gesunden Pferden 
 
Naglaa Gomaa, Albrecht Uhlig, Gerald F. Schusser 
 
Summary 
Seven adult, healthy, conscious warmblood horses were used in a crossover study. They were 
fed twice a day on 1 kg hay/100 kg BW and 0.5 kg concentrates with unlimited access to 
water. One hour after feeding, the contractive motility of the descending duodenum, cecal 
body and left ventral colon were measured using a 5 MHz transcutaneus ultrasonographic 
transducer. Each horse was treated with 0.9% NaCl (5 ml/100 kg BW; i. v.), and with 
Buscopan® compositum (BC) at its therapeutic dosage (25 mg/kg BW; metamizol-sodium, 
0.2 mg/kg BW; N-butylscopolammonium bromide, i. v.) in a control and an experimental trial 
respectively. The contractive motility was counted in a 3-min period immediately and 5, 15, 
30, 45, 60, 120, 180 and 240 min after application in both trials. There was an immediate, 
rapid and significant (p< 0.05) reduction of duodenal, cecal and left ventral colon contractions 
after BC administration. Cecal and left ventral colon contractions rapidly restored their 
normal contractions after 30 min, while duodenal contractions returned to the normal rate 
after 120 min of BC administration. It was concluded that Buscopan® compositum at its 
therapeutic dosage has an immediate, potent, short-lived reductive effect on cecum and left 
ventral colon contractions but a minor, longer effect on the duodenal contractions. Therefore, 
it is recommended for treatment of  spasmodic colic as well as spasms resulting from acute 
simple impaction in horses but it is not recommended for repeated short-interval 
administration. 
Keywords: Buscopan® compositum, intestinal motility, duodenum, cecum, left ventral colon, 
horses 
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 Zusammenfassung 
Sieben erwachsene, gesunde Warmblutpferde wurden in einer Crossover-Studie verwendet. 
Über zwei Wochen vor dem Versuch wurden die Pferde mit 1 kg Heu/100 kg KM und 0,5 kg 
Kraftfutter 2x/d gefüttert und hatten unbeschränkten Zugang zu Wasser. Am Versuchstag 
wurden eine Stunde nach der Fütterung die Kontraktionen vom Duodenum descendens (Dd), 
Blinddarmkörper (Bk) und der linken ventralen Längslage (Lv) mittels eines 5 MHz 
Ultraschallkopfes transkutan gemessen. Jedes Pferd wurde mit 5 ml/100 kg KM; 0,9% NaCl 
(Kontrollstudie) oder mit 5 ml/100 kg KM; Buscopan® compositum (BC) (therapeutische 
Dosis: 25 mg/kg KM; Metamizol-Natrium, 0,2 mg/kg KM; N-Butylscopolaminbromide) 
(Versuchsstudie) i. v. behandelt. Die Anzahl der Kontraktionen wurde in einem Zeitraum von 
jeweils 3 min in beiden Studien, und zwar vor, sofort nach sowie nach 5, 15, 30, 45, 60, 120, 
180 und 240 min nach der Applikation aufgezeichnet. Eine signifikante (p < 0,05) Reduktion 
in den untersuchten Darmabschnitten war unmittelbar nach der BC-Verabreichung 
feststellbar. Dreißig Minuten nach Applikation von BC waren die Kontraktionen beim Bk und 
der Lv wieder in physiologischer Anzahl vorhanden. Dagegen waren die 
Duodenalkontraktionen erst nach 120 min wieder im Normalbereich. Es wurde der Schluss 
gezogen, dass BC in seiner therapeutischen Dosis nicht nur eine sofortige, starke, kurzzeitige, 
reduktive Wirkung im Bk und in der Lv auslöst, sondern auch eine geringfügige Wirkung im 
Dd hat. Aufgrund der Ergebnisse ist BC sowohl zur Behandlung der Krampfkolik als auch zur 
Spasmolyse infolge primärer Verstopfung im Zäkum oder in der linken ventralen Längslage 
sehr gut geeignet. Ein wiederholter, kurzzeitiger Einsatz von BC in therapeutischer Dosis ist 
beim Pferd mit primärer Verstopfung nicht empfehlenswert. 
Schlüsselwörter:  Buscopan® compositum, Darmmotilität, Duodenum, Blinddarm, Kolon, 
Pferd 
 
Introduction 
Spasmolytic and analgesic drugs are widely used in the treatment of abdominal pain in horses 
(Davies and Gerring, 1983a). Mild or moderate pain is caused by increasing frequency of 
intestinal contractions as in spasmodic colic or spasms occuring oral to the intraluminal 
obstruction, such as in an impaction. Moreover, intestinal distension due to tympany or 
impaction or increasing the tension of mesenteric or nephrosplenic ligament leads to visceral 
pain (White and Edwards, 1999). Intestinal ischemia due to strangulation obstruction or 
nonstrangulating infarction yields most severe abdominal pain in horses with colic (Holbrook 
and Moore, 1996). Therefore, the abdominal pain must be relieved, not only for the safety and 
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 welfare of the horses, but also to prevent the injury of attendants and to facilitate the 
examination of horses with colic (Boatwright et al., 1996). 
 The approved formulation N-butylscopolammonium bromide with its trade name Buscopan® 
Injectable solution (Boehringer Ingelheim) is highly effective in relieving abdominal pain in 
horses with colic (Bertone, 2002; Luo et al., 2006). It reduces the contractive motility of the 
intestine by blocking the muscarinic receptors and relaxing the intestinal smooth muscle 
(Bertone, 2002). N-butylscopolammonium bromide is a quaternary ammonium compound 
derived from a belladonna alkaloid. It has a shorter duration of action comparable with 
atropine due to its negligible lipid solubility. It also exhibits fewer central nervous system side 
effects because it does not pass the blood-brain barrier (Boatwright et al., 1996). This drug 
has been used in Europe for more than 30 years in the treatment of horses with spasmodic 
colic and large colon impaction (Keller and Faulstich, 1985; Roelvink et al., 1991). The 
overdosage or repeated administrations of the drug could induce colic in horses (Keller, 
1986), or could lead to a prestenotic tympany and/or atonic cecum or left ventral colon in 
horses with primary cecal or left ventral colon impaction (Jaksch, 1982; Kraft, 1997). N-
butylscopolammonium bromide is commercially available in Europe as 
Buscopan® compositum (4 mg/ml N-butylscopolammonium bromide and 500 mg/ml 
Metamizol-Sodium). Metamizol-Sodium is a non-steroidal, anti-inflammatory drug which 
acts peripherally by inhibiting the biosynthesis of prostaglandins. Therefore, it has a 
synergistic effect with N-butylscopolammonium in relieving abdominal pain. This 
combination of butylscopolammonium bromide and Metamizol-Sodium provides an 
immediate relieving of pain for a longer duration (Roelvink et al., 1991).  
The equine intestinal tract expresses regional and specific motility patterns (Pfannkuche and 
Gäbel, 2007). The small intestinal contents move rapidly in aboral direction by both 
propulsive and segmental contractions. The large intestine especially the ventral colon, has 
another distinct motility pattern which includes non-rhythmic hausteral segmentation and 
rhythmic propulsive and retropulsive contractions. Cecal motility, in contrast, is largely 
composed of segmental contractions (Herdt, 2007). The complex function of the large 
intestine necessitates coordination of its motility to enable prolonged retention of the ingesta 
to facilitate microbial fermentation. Therefore, any disturbance in intestinal motility at these 
regions predisposes the horse to impaction or tympany (Roberts and Seawright, 1983). 
Such regional differences impact the treatment of equine abdominal pain resulting from 
motility disorders. Previous investigations of the intestinal motility have used either invasive 
techniques, such as implanted strain gauges or electrodes (Adams et al., 1984; Roger and 
Ruckebusch 1987; Clark et al., 1988; Rutkowski et al., 1989) or non-invasive, such as 
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 auscultation of borborygmi intestinal sounds, which had specific and sensitive limitations 
(Scrollavezza and Zanichelli, 1993). Recently, ultrasonography has been used as a non-
invasive method for assessing the intestinal motility in horses by transrectal (Freeman and 
England, 2001) or transabdominal examination (Uhlig and Schusser, 2002; Mitchell et al., 
2005; Sasaki et al., 2008). 
The present study aimed to investigate the effect of Buscopan® compositum at its therapeutic 
dosage on the contractive motility of various regions of the intestine in healthy conscious 
horses using transcutanous ultrasonography.  
 
Materials and Methods 
Animals 
Seven adult healthy Warmblood horses (one mare and 6 geldings) were used in a crossover 
study. The age of horses ranged from 9 to 17 years and body weight (BW)  from 440 to 660 
kg. None of those horses had gastrointestinal disorders or evidence of systemic diseases. Two 
weeks before starting the study, each horse was stabled on straw-bedded boxes and fed twice 
a day with 1 kg hay/100 kg BW and  0.5 kg concentrate with unlimited access to water. These 
trials were approved by the Veterinary Trial Commission. 
 
Protocol of the study 
Each horse underwent two trials. The first trial was carried out by counting the intestinal 
contractions at different regions (descending duodenum, cecal body, left ventral colon) after 
intravenous administration of saline (5 ml/100 kg BW; 0.9% NaCl) over a 3-minute period. 
The second trial included the counting of intestinal contractions at the same regions of the 
intestine following intravenous administration of 5 ml/100 kg BW; Buscopan® compositum, 
Boehringer Ingelheim Vetmedica GmbH, DE (manufactured therapeutic dosage: 
0.2 mg/kg BW; N-butylscopolammonium bromide (N-butylscopolamine bromide) and 
25 mg/kg BW; Metamizol-Sodium). As solid phase gastric emptying starts after 30 minutes of 
eating (Smyth 1988), the intestinal contractions were counted one hour after  starting feeding 
in both trials. They were counted over a period of 3 minutes before (pre-injection 
contractions) and after the administration (post-injection contractions) at the following time 
points: immediately (30 sec), 5 min, 15 min, 30 min, 45 min, 60 min, 120 min, 180 min, and 
240 min. Between  the monitoring periods, the horses had access to hay and water. 
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 Method 
Transcutaneous ultrasonographic examinations were performed for counting the intestinal 
contractions at the different regions according to Kirberger et al. (1995), Freeman  (2002) and 
Mitchell et al. (2005). The horses were restrained in stocks during ultrasonographic 
examinations. No sedatives were used during the study. The position of the descending 
duodenum, cecal body and left ventral colon in each horse was identified before the beginning 
of ultrasonographic examinations. The descending duodenum was located at the right 
thoracical area extending from the 8th to the 18th rib along the line joining the olecranon and 
tuber coxae. The cecal body was identified in the upper part of the right paralumbar region. 
However,  the left ventral colon was identified at the ventral part of the left paralumbar region 
at the level of the stifle. The abdomen was clipped bilaterally at those identified regions, 
cleaned with alcohol and then coupling gel was applied to enhance the contact with the probe. 
Abdominal ultrasonographic examination was performed with a 5 MHz curved-linear 
transducer (LOGIQ 5 PRO, GE Medical systems, JP). The transducer was oriented in a 
longitudinal direction for better visualizing the sacculations of cecum and left ventral colon. 
In contrast to the gas-filled cecal base and movable cecal apex, the cecal body wall is easy to 
identify based on the cecal body fluid content. The transducer was positioned in a cross-
sectional direction for the best visualization of the descending duodenum. Once the optimal 
imaging plane had been determined, the intestinal contractions were counted during a 3-
minute period and assessed by the movement of intestinal wall and luminal contents. In the 
descending duodenum, the numbers of duodenal distensions or circular contractions were 
counted. The contractions of the cecal body were associated with deviation of cecal wall from 
the transducer of more than 2 cm. Nevertheless, the contractions of left ventral colon were 
assessed by changes in its sacculations. 
 All ultrasonographic measurements were done after one hour of feeding at the same time of a 
day and were carried out by the same person to avoid  individual variations.  
 
Statistical analysis 
The data were statistically analyzed using a computer software programme (SPSS 15.0, 
GmbH Software, DE). The normal distribution of data was tested using Shapiro-Wilk test.  
Mean ± SEM (standard error of mean) of pre- and post-injection counting of the intestinal 
contractions were calculated. These values were plotted in run charts of the intestinal 
contractions against the monitoring period in both trials. The values were subjected to the t-
test for comparison between intestinal contractions after saline and after 
Buscopan® compositum administration. The significance was recorded at p ≤ 0.05.  
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Results 
The descending duodenum was constantly observed at 14th–15th intercostal space with varying 
visibility cranial and caudal to this region. It was seen between the liver and the right dorsal 
colon (Figure 1). At the more cranial locations, the lung field tended to interfere with the 
visualization of descending duodenum only during inspiration. The descending duodenum 
was usually flattened by adjacent organs and it was seen only during distension as a more oval 
to round shape (Figure 2). During ultrasonographic examination, it was visualized that the 
descending duodenum had two types of motility, segmental and propulsive contractions 
resulting in a rapid aboral movement of the ingesta.   
The bowel wall of cecal body or the left ventral colon appeared as a mobile structure outlined 
by a hypoechoic curve line overlying a hyperechoic gas shadow. The luminal contents and the 
opposite wall were not visualized due to the acoustic gas shadow. The cecal body was 
identified by its sacculations. It was seen adjacent to the right abdominal wall (Figure 3) while 
the left ventral colon was seen ventral to spleen and characterized by its haustrations (Figure 
4).  
In both cecum and left ventral colon, the normal motility comprised either localized 
segmental contractions (mixing) or propagating (propulsive) contractions in both forward and 
backward directions. By ultrasonographic examination, only the segmental (mixing) 
contractions were counted in all examined intestinal segments.  
Mean ± SEM of the recorded pre-injection intestinal contractions at the descending 
duodenum, cecal body and left ventral colon were 14 ± 1.2, 7 ± 0.8 and 
5.1 ± 0.3 contractions/3 min respectively. The mean values of intestinal contractions did not 
differ significantly during a four-hour monitoring period after saline adminstration. They were 
9.9 ± 0.7, 5.7 ± 0.5 and 4.1 ± 0.3 contractions/3 min at the descending duodenum, cecal body 
and left ventral colon respectively after 240 min of saline adminstration. 
Following the administration of Buscopan® compositum, the intestinal contractions were 
qualitatively and quantitatively reduced. There was a rapid significant (p < 0.05) reduction of 
duodenal contractions immediately after Buscopan® compositum administration (7 ± 2.4) in 
comparison to pre-injection duodenal contractions (13 ± 1.2) or duodenal contractions 
immediately after  saline administration (13 ± 1.4). There was a mean reduction of 46.2 % in 
duodenal contractions immediately after Buscopan® compositum application. This inhibitory 
effect lasted 60 min. The duodenal contractions returned to normal (9.7 ± 0.6) in comparison 
to the contractions (10.7 ± 1.3) after 120 min of saline administration (Figure 5). 
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 Immediately after Buscopan® compositum administration (~30 sec), the cecal contractions 
were significantly decreased (1 ± 0.7) in comparison to the contractions soon after saline 
administration (6.9 ± 0.9) or  the pre-injection cecal contractions (7.6 ± 0.5) with a mean 
reduction of 86.8 % of pre-injection contractions. The movements of cecal sacculations were 
impressively slow and the significantly reduced contractions were observed up to the 
measuring time of 15 min. The cecum restored its normal contractions (4.3 ± 1.1), 30 min 
after Buscopan® compositum administration in comparison to the contractions (6 ± 0.6) at the 
same time after saline administration (Figure 6). 
Directly after Buscopan® compositum administration, a significant reduction of the left 
ventral colon contractions (0.6 ± 0.4) was also observed in comparison to the rate immediate 
to saline administration (4.9 ± 0.4) or to the pre-injection counting (5.6 ± 0.6) with a mean 
reduction of 89.3 % of pre-injection contractions. The significant reduction lasted 15 min, 
whereas the numbers of colonic contractions returned to normal (4.9 ± 0.6) after 30 min in 
comparison to the contractions (4.7 ± 0.3) following saline administration (Figure 7). 
 
Discussion 
The descending duodenum has a relatively superficial fixed location during the abdominal 
ultrasonographic examination in horses (Kirberger et al., 1995). Based on this, the descending 
duodenum is the best model for examination of small intestinal motility carried out by 
transcutanous ultrasonography. In this study, the duodenal contractions were counted during 
the digestive phase, which is characterised by a more uniform rhythmic contractile activities 
of the small intestine, called segmental contractions, which are mixing of ingesta with 
digestive juice (Vantrappen and Janssens, 1984). The descending duodenal contractions were 
(14 ± 1.2)/3 min one hour after feeding and before saline adminstration. The great duodenal 
contractions are unique in horses to transport the ingesta as fast as possible to the large 
intestine, where the digestion of fiber starts (Davies and Gerring, 1983b). At the same time, 
the cecal and left ventral colon contractions were 7 ± 0.8 and 5.1 ± 0.3 contractions/3 min 
respectively. Owing to the reservoir function of cecum and large colon, they enable a 
prolonged retention of the ingesta for bacterial fermentation and digestion (Sellers et al., 
1984). Therefore, the contractile activities of the cecum and large colon were lower than of 
the descending duodenum.  
Despite the fact that motor activities of intestinal tract increase after feeding (Christensen, 
1985), the numbers of intestinal contractions at the described regions were not significantly 
different during a four-hour monitoring period after saline administration.. These values of 
intestinal contractions were comparable to those previously reported in healthy conscious 
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 horses using ultrasonographic technique (Kirberger et al., 1995; Freeman and England, 2001; 
Mitchell et al., 2005; Sasaki et al., 2008) which suggest that ultrasonography is a valuable and 
reproducible tool for non-invasive monitoring and quantification of intestinal contractions in 
horses. 
On the other hand, there was a rapid significant (p < 0.05) reduction of intestinal contractions 
following the intravenous administration of a therapeutic dosage of Buscopan® compositum. 
The effect of Buscopan® compositum occured immediatly after the administration and 
reached its maximum inhibitory effect within 15 min at all examined regiones of the intestine. 
In the duodenum, Buscopan® compositum provided a mean reduction of 46.2 % of pre-
injection contractions. However, they had a mean reduction of 86.8 % and 89.3 % in cecal 
and left ventral colon contractions respectively. These results are consistant with those of  the 
previous investigation on the effect of Buscopan® compositum on the small and large 
intestinal motor activities in rabbits (Radenković et al., 2003). It concluded that the inhibitory 
effect of N-butylscoplammonium bromide was most pronounced on the colonic contractions, 
whereas the duodenal motility was less affected. This could be attributed to the effect of N-
butylscopolammonium bromide on blocking the cholinergic muscarinic receptors which are 
more concentrated on the large colon and cecum than on the duodenum (Tytgat, 2007).  
Conversely, Buscopan® compositum induced a significant reduction of duodenal contractions 
for 120 min until the duodendum returned to its normal activity. However, the cecum and left 
ventral colon restored their normal contractions in 30 min after Buscopan® compositum 
adminstration. The longer effect of Buscopan® compositum on the duodenum in despite of the 
lower concentraction of muscarinic receptors on it can be explained by a parasympathetic 
ganglion-blocking effect of N-butylscopolammonium bromide via binding to nicotinic 
receptors (Tytgat, 2007; Weiser and Just, 2009).  
From the clinical view, this shows that, a single therapeutic dosage of Buscopan® compositum 
is very effective in the treatment of a spasmodic colic resulting from an increasing of irregular 
small intestinal contractions which last over a period of 15 minutes (Jaksch, 1982). However, 
the treatment of cecal or left ventral colon impaction with Buscopan® compositum has to be 
challenged. The effect of N-butylscopolammonium bromide on prolonging the time of gastric 
emptying can not be neglected (Goerg and Spilker, 2003; Américo et al., 2009). In addition, 
its effect on reducing the descending duodenal contractions (motility) after 
Buscopan® compositum administration could delay the passage rate of laxatives to the cecum 
and large colon and consequently delay the resolving of impaction. A long-term intestinal 
impaction as a result of prolonged treatment can affect the function of nerves and over-stretch 
intestinal smooth muscle due to severe impaction leading to atonic cecum or colon as well as 
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 adynamic ileus (Guyton, 1991; Schlag, 1996; White and Edwards, 1999). Therefore, the 
maintenance of intestinal propulsive motility in horses with cecal or left ventral colon 
impaction during treatment is very important in resolving the impaction (White and Lopes, 
2003). However, the repeated administrations of  Buscopan® compositum during treatment of 
intestinal impaction hinders the maintenance of this motility. 
Based on the pharmacokinetics, the terminal elimination half-life of N-butylscopolammonium 
bromide in plasma is approximately 5 hours (Samuels, 2009). In addition, our results 
demonstrated the inhibitory effect of Buscopan® compositum on the duodenal contractions 
which lasted for 2 hours. Therefore, repeated administrations of Buscopan® compositum in a 
period less than 5 hours could feasibly produce a level in the blood that produce effects 
analogous to atropine through its tendency to blocking the muscarinic and nicotinic receptors 
(Ducharme and Fubini, 1983; Weiser and Just, 2009).  
From this present study, it can be concluded that Buscopan® compositum in its single 
therapeutic dosage induces an immediate effective reduction of the contractive motility in all 
regions of the intestine. However, its inhibitory effect differs in intensity and duration. It has a 
potent short-lived effect on the cecum and left ventral colon and a little longer effect on the 
descending duodenum. Based on our results, a single therapeutic dosage of 
Buscopan® compositum is effectively suitable in the treatment of abdominal pain resulting 
from a spasmodic colic as well as spasms oral or around the impaction. However, Buscopan® 
compositum could not be recommended for a repeated short-interval administration especially 
for the treatment of  cecal or large colon impaction. 
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Figure 1: Transcutaneous ultrasongraphic image of the descending duodenum (D) which was 
located between the liver (L) and right dorsal colon (C). 
 
Figure 2: Transcutaneous ultrasongraphic image of  the  duodenum during segmental 
dilatation  
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Figure 3: Transcutaneous ultrasongraphic image of the body of the cecum which is 
characterized by sacculations. 
 
 
 
Figure 4: Trascutanus ultrasongraphic image of left ventral colon ventral to spleen 
characterized by its haustrations. 
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Figure 5: The duodenal contractive motility in healthy conscious horses after administration 
of 5 ml of saline/100 kg BW or 5 ml Buscopan® compositum/100 kg BW. Each plot 
represents the numbers of duodenal contractions/3 min against the 4 hour monitoring period.  
* Significance difference, p < 0.05.  
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Figure 6:  The cecal contractions in healthy conscious horses after administration aof 5 ml of 
saline/100 kg BW or  5 ml Buscopan® compositum/100 kg BW Each plot represents the 
numbers of cecal contractions/3 min against the 4 hour monitoring period.  
* Significance difference, p < 0.05.  
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Figure 7: The left ventral colon contractions in healthy conscious horses after administration 
of 5 ml of saline/100 kg BW or  5 ml Buscopan® compositum/100 kg BW Each plot 
represents the numbers of colon contractions /3 min against the 4 hour monitoring period.   
 * Significance difference, p < 0.05. 
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3 Discussion 
The fat mobilization have been studied more in ponies than in horses, because the greater 
occurrence of hyperlipemia disease syndrome in ponies (SCHOTMAN and KRONEMAN 
1969; BAETZ et al. 1972; MORRIS et al. 1972; WENSING et al. 1973; GAY et al. 1978). 
Hyperlipemia and hyperlipidemia are characterized by a moderate or severe elevation of 
plasma triglycerides in some of fasting ponies, donkeys, mules or horses as it appears to be 
unique for the equine species (MORRIS et al. 1972; FREESTONE et al. 1991; FORHEAD et 
al. 1995; FRANK et al. 2002). The hyperlipidemia in horses has been associated with a 
period of negative energy balance and stress (JEFFCOTT and FIELD 1985). Therefore, it is 
usually observed in horses or ponies admitted to clinics for the treatment of diseases 
associated with food deprivation and colic (SCHOTMAN and WAGENAAR 1969; 
BARTLEY 1970; MOGG and PALMER 1995). Hyperbilirubinemia has been observed also 
in fasting horses (GRONWALL and MIA 1972; ENGELKING 1993). It was considered to 
be associated with increasing NEFA in circulation (GRONWALL and MIA 1972). 
In this study, we investigated the fat mobilization in horses with an impaction in left ventral 
colon during the period of hospitalization. The investigation was carried out in a comparison 
with healthy horses which were withheld of feed over night (period of 12 hours and kept on 
straw bedding or unbedding boxes (protocols A and B) respectively. This period of time was 
chosen since most animals undergo a natural feeding/fasting cycle of approximately 12 hours. 
In comparison to horses in protocol A, serum NEFA and total bilirubin (TB) were 
significantly increased in horses with impaction in left ventral colon at admission, whereas 
serum triglycerides remain unchanged. Since NEFA are the first serum lipids components to 
rise after caloric deprivation (NAYLOR et al. 1980a), anorectic horses with an impaction in 
left ventral colon had a significant increase in serum NEFA at admission. Nevertheless, this 
elevation of NEFA in horses with left ventral colon impaction was comparable to that was 
observed in horses in protocol B. This means that the fat mobilization during fasting in 
healthy horses kept in unbedded boxes for 12 hours was similar to that occurred in inappetent 
horses with left ventral colon impaction. The reason of increase NEFA concentrations in 
horses in protocol B as well as the horses with left ventral colon impaction could be 
attributed to the negative energy balance due to feed withdrawal in healthy horses and due to 
anorexia in horses with impaction. In addition, pain in horses with colic induces cortisol 
secretion which stimulates hormone sensitive lipase and reduces the efficiency of circulating 
insulin (JAWORSKI et al. 2007). This mechanism enhances fat mobilization from adipose 
tissue leading to increase the level of NEFA in circulation. No doubt that a level of stress felt 
by horses kept on unbedded boxes is an additional cause of enhancing the fat mobilization in 
protocol B (McGREEVY et al. 1995; COOPER and McGREEVY 2003). On the contrary, the 
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horses which were kept on straw bedded boxes (protocol A) were able to eat from their straw 
bedding which could stabilize fat mobilization and prevent the elevation of NEFA 
(GRONWALL and ENGELKING 1982).  
A significant elevation of TB was also observed in horses with left ventral colon impaction at 
admission in comparison to horses in protocols A and B. The median duration of colic and 
anorexia in horses with large colon impaction prior to referral was 24 hours. The 
hyperbilirubinemia in these horses is similar to the fasting hyperbilirubinemia in horses 
fasted over 18 hours which was reported by GRONWALL and MIA (1972). Fasting 
hyperbilirubinemia was attributed to the decrease of hepatic clearance of direct 
(unconjugated) bilirubin due to a competition with NEFA for hepatic uptake (GRONWALL 
and MIA 1972; ENGELKING 1993).  
During the period of hospitalization and treatment of impaction, the horses were muzzled and 
prevented from food intake which lasted till the impaction was no longer palpated per rectum 
(median 2 days). After resolving the impaction, there was a significant increase in serum 
triglycerides in comparison to its level at admission. Similar finding was reported by 
NAYLOR et al. (1980a), where serum triglycerides began to rise after 40 hours of caloric 
deprivation, presumably because of a time lag between hepatic extraction of NEFA from 
circulation and their reesterification to triglycerides which were then released back into 
blood. In contrast, NEFA concentrations after resolving the impaction and refeeding were 
lower than their concentrations at admission. This is explained by the hepatic uptake of 
NEFA from circulation where the rate of NEFA removal proportional to their serum 
concentration (VARANIC 1975). Since the fasting hyperbilirubinemia in horses results from 
a decrease in hepatic removal of unconjugated bilirubin, the plasma bilirubin increases during 
treatment of impaction until the hepatic removal return to its balance (GRONWALL and 
MIA 1972). Therefore, after resolving the impaction, serum total bilirubin did not return to its 
normal level very fast. On the contrary, 50% of horses returned to normal levels of serum 
NEFA after resolving the impaction. This is consent with previous studies reported that 
NEFA concentrations decrease rapidly after refeeding while triglycerides and total bilirubin 
return to normal within 2 to 7 days after refeeding (GRONWALL and ENGELKING 1982; 
DUNKEL and MCKENZIE 2003). The uptake of triglycerides at tissues sites is mediated by 
lipoprotein lipase which is responsive to insulin. Therefore, refeeding can affect the rate of 
triglyceride clearance (MOSER et al. 1993). The interesting is that the horses even in feeding 
state have a lesser ability to clear triglycerides than other species. Between the equine species 
there is a breed difference related to the type of muscle fiber and oxidative capacity of muscle 
fiber. Arabian horses may be better adapted for lipid metabolism than Quarter horses and the 
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Thoroughbred is intermediate to Arabian and Quarter horses (MOSER et al. 1993). 
Therefore, the rate of returning of triglycerides to its normal is also breed determinable.  
The present study showed that a mild hypertriglyceridemia can be developed in horses with 
impaction in left ventral colon as a result of feed restriction and fat mobilization during the 
period of treatment. This is similar to fasting hypertriglyceridemia in horses reported by 
NAYLOR et al. (1980a) after 64-hours of feed withdrawal. MORRIS et al. (1972) assumed 
that fasting hypertriglyceridemia may result from an inability of peripheral tissue to utilize 
VLDL rather than from a defect in hepatic synthesis. This hypertriglyceridemia is reversible 
after refeeding, whereas the accumulation of lipids in serum can become pronounced if 
mobilization of lipid is prolonged or is accompanied by delaying in the removal of lipids 
from serum as in cases of insulin resistance or azotemia (NAYLOR et al. 1980a). 
Furthermore, hypertriglyceridemia could be associated with inflammatory processes in horses 
as a result of increasing the oxidative capacity and mitochondrial reactive species which 
indirectly enhances the pro-inflammatory mediators (TRIPATHY et al. 2003 and VICK et al. 
2007). Therefore, it is important to measure and monitor serum triglycerides and total 
bilirubin in horses presented for the treatment of large colon impaction and during the period 
of treatment. If the impaction persisted for more than two days and serum triglycerides 
progressively elevated, partial parenteral nutrition is recommended. 
Based on a secondary impaction a strangulation obstruction could be the reason. Clinical 
investigation and clinical pathological findings are important to decide for surgical treatment. 
Strangulating intestinal obstructions are still a major cause of illness and death in horses 
(COHEN et al. 1995; TINKER et al. 1997). It is clear that strangulating lesion is an 
indication for surgical intervention. Considering the risks of surgery, postoperative 
complications and the costs involved, it is necessary to find parameters that can help in 
determining the need for surgery and prognosis. 
Alcohol dehydrogenase (ADH) is a cytosolic hepatic enzyme found mainly in centrilobular 
region of the liver acinus (zone 3) (KATO et al. 1990). It is considered a more sensitive 
biochemical indicator of hepatocellular injury due to hypoxia or decrease of blood flow 
(PARKS and GRANGER 1988; SHIMOJIMA et al 2007). Recently, it is considered as a 
marker of intestinal ischemia (GUMASTE et al. 2005). 
To our knowledge, there is no literature about serum ADH activity in horses; therefore, we 
attempted to assay ADH activity in healthy horses as a control group for comparison with 
other groups of horses with acute intestinal obstruction. In this study, there was a significant 
increase of serum ADH activity in horses with small intestinal strangulation and colon torsion 
in comparison to horses with non-strangulation obstruction or the control group. 
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Additionally, the horses with non-strangulation obstruction had a significant elevation of 
ADH activity in comparison to the control group but still lower than in horses with intestinal 
strangulation. This could be explained by a critical reduction of blood supply and tissue 
hypoperfusion created by luminal and vascular obstruction in horses with intestinal 
strangulation. In addition the horses with non-strangulation obstruction had a degree of 
intestinal hypoperfusion as a result of intestinal distension (DABAREINER et al. 2001). The 
intestinal venous obstruction or hypoperfusion causes regional and systemic 
immunoinflammation (MOORE and MOORE 1994). It is characterized by an excessive 
release of pro-inflammatory mediators which lead to activation of adhesive molecules in 
endothelial cells and leukocytes. This promotes adhesion and sequestration of leukocytes in 
paranchymal organs and ultimately leads to multiple organ dysfunction (BHATIA and 
MOOCHHALA 2004). Intercellular adhesion molecule (ICAM) is expressed strongly on 
sinusoidal lining hepatic cells leading to migration and recruitment of leukocytes into 
sinusoids (SHERLOCK and DOOLEY 2002). Consequently the increase of the numbers of 
non-perfused hepatic sinusoids leads to hepatic hypoxia especially at perivenous area (zone 
3), where oxygenation is poor (WANLESS 2009). ADH is abundantly distributed in the 
centrilobular area, which is sensitive to such decrease of blood flow. Therefore, ADH showed 
high activities in conditions associated with decrease of hepatic blood flow (BUEHLER et al 
1982 and KATO et al 1990). 
Meanwhile, intestine and liver which behave as one unit (splanchnic unit), house a vast 
reservoir of immune cells, in particular Kupffer cells, which are activated by 
proinflammatory cytokines and recruitment of neutrophilic granulocytes resulting in 
formation of reactive oxygen species (ROS). Lipid peroxidation (LPO), mediated by ROS, 
produces a variety of reactive products leading to a reversible hepatic injury (JAESCHKE 
2006). As ADH has the smallest molecular weight rather than hepatic transaminase, it can be 
much earlier detected in blood as a result of centrolobular hepatic injury (PARKS and 
GRANGER 1988). 
Furthermore, the necrosis of intestinal mucosa during strangulating obstruction permits 
absorption of endotoxins into the systemic circulation which plays a role in activation of 
hepatic ADH gene transcription (OIKAWA and YAMAOKA 2003). ADH is also a natural 
constituent of intestinal epithelium. Therefore, an additional increase in serum ADH activity 
could follow its release from the necrotic intestinal epithelium (ASHMARIN et al. 2000). 
On the other hand, the levels of other hepatic enzymes activities were varied among groups 
of horses. The level of AST activity was only significantly increased in horses with colon 
torsion (group 3). This elevation could occur subsequent to muscle damage from excessive 
intraluminar pressure on colon (MOORE et al. 1998). Additionally, the damage of colon 
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mucosa as a result of colon torsion leads to a more endotoxin absorption and consequently 
elevation of GLDH in group 3 (GRULKE et al. 2008). However, another hepatic 
transaminase (GGT) was not significantly increased in all groups of horses with acute 
intestinal obstruction when compared to the control group. This diversity of hepatic enzymes 
activity in serum attributed to the zonal distribution of various liver enzymes. The hepatic 
enzymes (AST and GGT) are distributed in the periportal region of liver and are released 
only in case of severe hepatic damage. The rapid clinical course of intestinal ischemia may 
not allow time for this prominent damage in the liver and release of these transaminases 
(MOORE et al. 1998). In contrast, ADH is a cytosolic liver enzyme which predominately 
distributed in the centrilobular (perivenous) region and released even with mild hepatic injury 
(PARKS and GRANGER 1988). 
There was leucocytosis with left shift in most horses of groups 2 and 3 whereas others 
showing leucopenia with toxic changes in granulocytes. In addition, the tachycardia and 
tachyponea which indicate the presence of systemic inflammatory response syndrome (SIRS) 
or sepsis in group 2 and 3 (OIKAWA and YAMAOKA 2003). 
Most horses diagnosed with acute intestinal obstruction in this study had a significant 
increase of serum lactate concentration. Hyperlactatemia in horses especially in groups 2 and 
3 could not only be attributed to excessive production of L-lactate from hypoperfused 
intestinal region but also to the shift in the metabolic pathway during sepsis (VARY 1996). 
Lactate production occurs whenever the rate of pyruvate formation exceeds its oxidation by 
the mitochondaria. The pyruvate dehydrogenase catalyzes the first irreversible reaction in 
mitochondrial oxidation of pyruvate. During sepsis, there is inhibition of mitochondrial 
pyruvate dehydrogenase as a result of damage of mitochondria by inflammatory mediators. 
This leads to increase pyruvate concentrations and consequently an increase in lactate 
production (VARY 1996). In view of the fact that endotoxins activate ADH mRNA 
transcription in liver leading to a significant elevation of serum ADH in serum (POTTER et 
al. 2003). Therefore, sepsis or endotoxemia in horses with colon torsion could be the cause 
for the presence of a significant positive correlation between lactate concentration and ADH 
activity in serum. The liver injury or hypoperfusion is not usually the cause of 
hyperlactatemia during sepsis (DE BACKER et al. 2001). The liver injury elected by 
intestinal strangulation is a revisable, centrilobular, neutrophile-mediated injury (POGGETTI 
et al 1992). Therefore, there was no correlation between hyperlactatemia and hepatic 
transaminases in horses with acute intestinal obstruction.  
Considering the diagnostic and prognostic values of ADH activity in horses with acute 
intestinal obstruction, a cut-off value which differentiates horses with non-strangulation 
obstruction from horses with strangulating obstruction and indicates the need of surgical 
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intervention was chosen. Moreover, another cut-off value which distinguishes survived 
horses from non-survived after surgery was calculated. On the base of our finding in the 
present study, horses with clinical signs of intestinal obstruction and serum ADH activity 
greater than 20 U/l may be considered to have strangulating obstruction or a degree of 
intestinal ischemia as a result of sever intestinal distension (80.56% specificity and 80.49% 
sensitivity).  
Outcome based on ADH assay in horses with strangulation obstruction was also evaluated. 
Serum ADH activity greater than 80 U/l had 94.44% specificity and 66.67% sensitivity of 
non-survival in horses with strangulating obstruction. Only one survivor was misclassified as 
non-survivor and four non-survivors were misclassified as survivors. The survived horse with 
ADH activity greater than 80 U/l had small intestinal incarceration in epiploic foramen. 
During surgery, only reposition of the herniated bowel was necessary without any surgical 
resection. The elevation of ADH activity in this case could be explained by partially 
occlusion of the caudal vena cava and the hepatic portal vein during entrapment resulting in 
decreasing venous return to heart and hepatic hypoperfusion (VASEY 1988). However, most 
horses that failed to survive and had ADH activity lower than 80 were euthanized 
postoperatively due to postoperative complications. 
This study provides a new clinical value of serum ADH activity in horses with acute 
intestinal obstruction as a diagnostic and prognostic indicator of strangulating obstruction.   
The method of spectrophotometric assay of ADH in this study was easy to use, required short 
time (5 min) to perform, may be a useful component in the clinical assessment and 
prognostication of horses with acute intestinal obstruction 
Since there are many clinical and paraclinical variables did not considered in this study and 
these could effect on the prognosis, it is recommended to use ADH as a prognostic value with 
other variables in multivariate model for predication of prognosis. 
The cornerstone of managing a horse with colic is the decision whether the horse needs 
surgical or conservative treatment. But horses with recommended surgical treatment need 
good prognostic values which makes it easier for owner’s decision. Ninety percent of colic 
cases resolve with appropriate medical treatment (DUKTI and WHITE 2008). 
Pain management in equine colic is considered an essential step in medical treatment. There 
are several drugs available to relieve the pain associated with colic in horses. Some have a 
sedative effect, others are anti-inflammatory. Drugs often employed in the treatment of colic 
cases modify intestinal motility. These drugs also vary in their potency and their duration of 
action (DRIESSEN 2007). Often veterinary surgeons use short-acting analgesics as they can 
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evaluate whether the colic episode has resolved or not. However, the long-acting analgesics 
are usually masking the signs of abdominal pain while intestinal disease is getting 
progressively worse. 
Buscopan® compositum is a spasmolytic, anti-cholinergic drug that acts predominantly on 
the smooth muscle of gastrointestinal tract. It is commonly used in the relief of intestinal 
spasm and returns intestinal motility to normal (BERTONE 2002).  
In this study, we attempted to investigate the effect of Buscopan® compositum on the 
intestinal motility in different regions of the intestine in conscious healthy horses which could 
indirectly provide some insight into the regional difference in the pain reliving effect of 
Buscopan® compositum. 
The present experimental study have shown that the contractive motility in duodenum, cecum 
and left ventral large colon of horses are inhibited by Buscopan® compositum 
(5ml/kg BW=0.2 mg/kg BW; N-butylscopolammonium bromide and 25 mg/kg BW; 
metamizol-sodium)  
Comparisons of the reduction of contractions among the intestinal regions suggest that the 
inhibitory effect of Buscopan® compositum is relatively weak in the descending duodenum, 
compared with other regions. As in the duodenum, Buscopan® compositum provided a mean 
reduction of 46.2% of pre-injection contractions. However, Buscopan® compositum has a 
mean reduction of 86.8% and 89.3% in cecal and left ventral colon contractions respectively. 
The duration of a significant reduction of intestinal contractions tended to be relatively 
shorter in cecum and left ventral colon than in the descending duodenum. 
Buscopan® compositum induced a significant inhibition of cecum and left ventral colon 
contractions for 30 min before they restored their normal contractions. However, the 
duodenal contraction was significantly reduced for 120 min after Buscopan® compositum 
administration until it returned to normal contractions. 
The reason for the regional difference of the effect of Buscopan® compositum on the 
intestinal contractive motility could be attributed to the effect of N-butylscopolammonium 
bromide on blocking the cholinergic muscarinic receptors which are more concentrated on 
the large colon and cecum than on the duodenum (TYTGAT 2007).  Despite of lower 
concentrations of muscarinic receptors on the duodenum, Buscopan® compositum has longer 
effect on the duodenum contractions. This can be explained by a parasympathetic ganglion-
blocking effect of N-butylscopolammonium bromide via binding to nicotinic receptors 
(TYTGAT 2007; WEISER and JUST 2009).  
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Based on these findings, a single therapeutic dosage of Buscopan® compositum is very 
effective in the treatment of a spasmodic colic episode which results from an irregular 
increase of small intestinal contractions and lasts over a period of 15 minutes (JAKSCH 
1982). However, the treatment of cecal or left ventral colon impaction with 
Buscopan® compositum is questionable for many reasons. The effect of N-
butylscopolammonium bromide on prolonging the time of gastric emptying cannot be 
neglected (GOERG and SPILKER 2003; AMERICO et al. 2009). It was observed in this 
study that duodenal contractions were significantly reduced after administration of 
Buscopan® compositum. This delays the passage rate of laxatives to the cecum and large 
colon and consequently the resolving of impaction. The delay of impaction resolving can 
affect the function of nerves due to over-stretch intestinal smooth muscle leading to atonic 
cecum or colon as well as adynamic ileus (GUYTON 1991; SCHLAG 1996; WHITE and 
EDWARDS 1999). Moreover, the repeated administrations of Buscopan® compositum in a 
period less than 5 hours (the terminal elimination half-life), could feasibly reach a level in the 
blood producing atropine analogous effects through its tendency to blocking the muscarinic 
and nicotinic receptors (SAMUELS 2009; DUCHARME and FUBINI 1983; WEISER and 
JUST 2009). Therefore, the repeated injection of Buscopan® compositum during treatment of 
intestinal impaction hinders the maintenance of normal intestinal motility which is very 
essential during treatment of impaction.  
From this present study, it can be concluded that inhibitory effect of Buscopan® compositum 
on the intestinal contractions differs in intensity and duration from region to another. It has a 
potent short-life effect on the cecum and left ventral colon and a minor long effect on the 
descending duodenum. Based on our results, a single therapeutic dosage of 
Buscopan® compositum is effectively suitable in treatment of abdominal pain resulting from 
a spasmodic colic as well as spasms oral or around the impaction. However, 
Buscopan® compositum could not be recommended for repeated short-interval 
administrations especially for the treatment of cecal or large colon impaction. 
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4 Summary 
Naglaa Abdel Magid Gomaa 
Clinical and clinicopathological studies in healthy horses and horses with colic 
Large Animal Clinic for Internal Medicine, Faculty of Veterinary Medicine, Leipzig 
University  
71 pages including copies of 3 publications, 96 references, appendix 
Keywords: triglycerides, free fatty acids, bilirubin, alcohol dehydrogenase, 
Buscopan® compositum, intestinal motility, intestinal obstruction, horses. 
Introduction: In order to investigate the effect of food restriction on fat mobilization in 
horses with impaction in left ventral colon during treatment, serum triglycerides, NEFA and 
total bilirubine (TB) were measured before and after treatment. On another side, the 
determination of alcohol dehydrogenase (ADH) activity in serum could facilitate the 
distinguishing of the non-strangulating intestinal obstruction from the potential fatal 
strangulation obstruction and could submit a new prognostic biochemical parameter for 
intestinal strangulation. With the intention of giving a highlight over the analgesic effect of 
Buscopan® compositum in horses with colic, it was attempted to investigate the effect of 
Buscopan® compositum on the intestinal motility of healthy conscious horses in different 
regions of intestine. 
Material and Methods: First study included 39 horses in a retrospective study. The horses 
were admitted to the clinic between January 2005 and February 2008 with an impaction of 
left ventral colon. From only 12 horses, serum triglycerides, NEFA and TB were measured 
before and after resolving the impaction.  
Second study was a prospective study. It included 30 healthy horses as a control group and 
77 horses with acute intestinal obstruction which were divided into non-strangulation 
obstruction; 36 horses, small intestinal strangulation; 22 horses, and colon torsion; 19 horses.  
Third study included 7 healthy conscious horses were used in a crossover study. Each horse 
was treated with 0.9% NaCl and with Buscopan® compositum at its therapeutic dosage and 
the intestinal contractions were counted immediately and during 4 hours after treatment. 
An automatic analyzer (Hitachi 912) was used for measuring triglycerides, NEFA, TB, 
lactate, AST, GGT and GLDH in serum. Spectrophotometric method for assaying ADH 
activity in serum was used. Transcutaneous ultrasonographic examinations were performed 
for counting the intestinal contractions at descending duodenum, body of cecum and left 
ventral colon. 
Results: A significant elevation of NEFA and TB was observed in horses with impaction in 
left ventral colon at admission. By relieving the impaction, there was a significant elevation 
of triglycerides in comparison to its level at admission. 
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There was a significant increase in ADH activity in all horses with acute intestinal 
obstruction. ADH activity was significantly higher in horses with strangulation in 
comparison to non-strangulation obstruction. There was only a significant correlation 
between ADH and lactate in horses with non-strangulation obstruction and colon torsion. 
Only AST and GLDH were significantly increased in horses with colon torsion. ADH 
activity > 20 U/l had 80.56% specificity and 80.49% sensitivity for discriminating horses 
with intestinal strangulation from non-strangulation obstruction. ADH activity < 80 U/l had 
94.44% specificity and 66.67% sensitivity for survival.  
Buscopan® compositum had an immediate, rapid and significant (p< 0.05) reduction of 
duodenal, cecal and left ventral colon contractions after application. Cecal and left ventral 
colon contractions restored rapidly their normal contractions after 30 min, while duodenal 
contractions returned to the normal rate after 120 min of Buscopan® compositum 
administration. 
Conclusions: The horses with impaction in left ventral colon are susceptible to fat 
mobilization during the period of treatment as a result of food restriction. It was 
characterized by a revisable hypertriglyceridemia and hyperbililrubinemia.  
Serum ADH activity could have a useful clinical value in detecting the intestinal 
strangulation and predicting the prognosis in horses with intestinal strangulation. 
Buscopan® compositum at its therapeutic dosage has an immediate, potent, short-lived 
reductive effect on cecum and left ventral colon contractions but a minor, longer effect on 
the duodenal contractions. Therefore, it is thought to be more effective in treatment of 
spasmodic colic than in large colon impaction. 
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5 Zusammenfassung 
Naglaa Abdel Magid Gomaa 
Klinische und klinisch-pathologische Studien von gesunden Pferden und Pferden mit 
Kolik 
Medizinische Tierklinik, Veterinärmedizinische Fakultät, Universität Leipzig 
71 Seiten, 3 Publikationen, 96 Literaturzitate, Anhang 
Schlüsselwörter: Triglyceride, freie Fettsäuren, Bilirubin, Alkoholdehydrogenase, 
Buscopan® compositum, intestinale Motilität, intestinale Obstruktion, Pferde. 
Einleitung: Um den Effekt der Nahrungskarenz auf die Fettmobilisation bei Pferden mit 
Verstopfung der linken ventralen Längslagen des Kolons während der Behandlung zu 
untersuchen, wurden Triglyceride (TG), freie Fettsäuren (FFS) und Gesamtbilirubin (GB) 
bestimmt. Andererseits ermöglicht die Bestimmung der Aktivität der Alkoholdehydrogenase 
(ADH) im Serum die Unterscheidung zwischen einer nichtstrangulierenden intestinalen 
Obstruktion und einer potentiell tödlichen Strangulation. ADH kann somit als ein neuer 
prognostischer biochemischer Parameter für die intestinale Strangulation eingesetzt werden. 
Um den spasmolytischen Effekt von Buscopan compositum bei Pferden mit Kolik zu 
untersuchen, wurde der Effekt von Buscopan compositum auf die intestinale Kontraktion 
von gesunden Pferden in verschiedenen Regionen des Darmes getestet. 
Material und Methoden: Die erste Publikation umfasst 39 Pferde in einer retrospektiven 
Studie. Diese Pferde wurden zwischen Januar 2005 und Februar 2008 in die Medizinische 
Tierklinik mit einer Verstopfung der linken ventralen Längslagen überwiesen. Nur bei 12 
von diesen Pferden wurden TG, FFS und GB im Serum vor und nach der Behandlung der 
Verstopfung gemessen. 
Die zweite Publikation: stellt eine prospektive Studie vor. Sie beinhaltet 30 Pferde als 
Kontrollgruppe und 77 Pferde mit akuter intestinaler Obstruktion, die in 3 Gruppen 
(nichtstrangulierende Obstruktion: 36 Pferde, Dünndarmstrangulation: 22 Pferde, 
Kolontorsion: 19 Pferde) eingeteilt wurden.  
Die dritte Publikation beschreibt eine Crossover-Studie mit 7 gesunden Pferden. Jedem 
Pferd wurde 0,9% NaCl oder Buscopan® compositum in der therapeutischen Dosierung 
verabreicht. Nach der Applikation wurden die intestinalen Kontraktionen in den folgenden 
nächsten 4 Stunden gezählt. 
Die Bestimmung von TG, FFS GB, Laktat, AST, GGT und GLDH im Serum erfolgte an 
einem Automaten (Hitachi 912). Für die Bestimmung der Aktivität der ADH im Serum 
wurde eine spektrophotometrische Methode verwendet. 
Für die Zählung der intestinalen Kontraktionen im Duodenum descendens, Zäkum und im 
linken ventralen Kolon erfolgte mittels transkutaner Ultraschalluntersuchung.  
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Ergebnisse: Eine signifikante Erhöhung der FFS und des GB wurde bei Aufnahme von 
Pferden mit einer Verstopfung in der linken ventralen Längslagen festgestellt. Nach der 
Behandlung der Verstopfung konnte eine signifikante Erhöhung der Konzentration von TG, 
bezogen auf die TG Konzentration bei Aufnahme in die Klinik, festgestellt werden.  
Bei Pferden mit akuter intestinaler Obstruktion wurde eine signifikante Erhöhung der 
Aktivität der ADH beobachtet. Die Aktivität der ADH war bei Pferden mit einer 
Strangulation signifikant höher als bei Pferden, die eine nichtstrangulierende Obstruktion des 
Darmes hatten. Bei Pferden mit einer nichtstrangulierenden Obstruktion oder einer 
Kolontorsion wurde eine positive Korrelation zwischen der ADH-Aktivität und der 
Laktatkonzentration im Serum festgestellt. Nur bei Pferden mit Kolontorsion waren die 
Aktivitäten von AST und GLDH signifikant erhöht. Für die Unterscheidung zwischen 
Pferden mit einer intestinalen Strangulation oder einer nichtstrangulierenden Obstruktion 
wurde für die ADH- Aktivität größer als 20 U/l eine Spezifität von 80,56% und eine 
Sensitivität von 80,49% ermittelt. Eine ADH-Aktivität kleiner 80 U/l zeigt, mit einer 
Spezifität von 94,44% und einer Sensitivität von 66,67%, eine günstige Prognose für das 
Überleben des Pferdes an. 
Nach Gabe von Buscopan® compositum trat eine sofortige schnelle und signifikante 
(p<0,05) Reduktion der Kontraktionen im Duodenum, Zäkum und den linken ventralen 
Längslagen ein. Die Kontraktionen des Zäkums und der linken ventralen Längslagen 
normalisierten sich schnell innerhalb von 30 min, wogegen die Kontraktionen des 
Duodenums erst 120 min nach der Applikation von Buscopan® compositum den 
Normalzustand erreichten. 
Schlussfolgerungen: Pferde mit einer Verstopfung in der linken ventralen Längslagen des 
Kolons sind während der medizinischen Behandlung anfällig für Fettmobilisation aufgrund 
der reduzierten Futteraufnahme. Dies ist gekennzeichnet durch eine reversible 
Hypertriglyceridämie und eine Hyperbilirubinämie.  
Die Aktivität von ADH im Serum kann ein nützlicher klinischer Parameter sein, um eine 
intestinale Strangulation zu identifizieren und bietet sich auch als prognostischer Marker bei 
intestinaler Strangulation an. 
Die Applikation von Buscopan® compositum in der therapeutischen Dosierung hat eine 
sofortige, potente und kurzzeitige Reduktion der Kontraktionen des Zäkums und der linken 
ventralen Längslage aber einen geringen und länger anhaltenden Effekt auf die duodenalen 
Kontraktionen zur Folge. Daraus folgt, dass Buscopan® compositum bei der Behandlung von 
Krampfkoliken effektiver ist als bei Verstopfungen des großen Kolons. 
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